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ABSTRACT
Since the arousal of the “glia” concept, 150 years ago, the knowledge on the features of 
glial cells, especially astrocytes, has been dramatically evolving. These star-shaped cells that 
lack axons not only participate in brain metabolism, supporting neuronal activity, but also 
can modulate the neurotransmission by modulating synapses. From taking part in the 
“tripartite synapse” to the astrocytic excitability - based on intracellular Ca2+ increases - and 
gliotransmission, astrocytes have been given the relevance that raises the idea that such glial 
modulation at cellular level should have greater implications in higher brain functions. 
However, these remarkable astrocytic features, as well as its influence in modulation of 
behaviour outputs, are still under-explored. In the attempt to contribute to the progress of 
our knowledge on these cells purpose in the brain, we decided to investigate the astrocytic 
component of the neuron-astrocyte interactions in complex cognitive processes that rely on 
the prefrontal cortex, analysing the behavioural performance of two animal models of 
astrocytic pathology. For that purpose, we implemented a rat model of pharmacological 
astrocytic ablation in the medial prefrontal cortex, through bilateral intracranial injections of 
the gliotoxin L-α-aminoadipate, and the transgenic dnSNARE mouse model, that displays 
conditional blockade of gliotransmitters vesicular release in astrocytes.
From the behaviour assessment of the rats subjected to the bilateral intracranial injections 
of L-α-aminoadipate we could conclude that the astrocytic ablation in the medial prefrontal 
cortex affects the attentional set-shifting, the working memory and the reversal learning. 
Microscope analysis of brain sections of the gliotoxin-injected animals revealed that astrocyte 
depleted regions were confined to the prelimbic and cingulate cortex, where the neuronal 
population was not affected. The genetic mouse model of conditional blockade of vesicular 
release in astrocytes was characterised in a more extensive way. We show here that these 
animals do not display anxious phenotype or have locomotor difficulties. Most importantly 
dnSNARE animals have shown impaired spatial reference memory (hippocampus-
dependent) and improved working memory, but normal reversal learning (prefrontal cortex-
dependent functions). Both astrocytes and gliotransmission seem to be crucial for cognitive 
computation and may represent a new window of understanding of brain function that 
urges to be clarified in terms of cellular pathways and biochemical mechanisms.
The successful implementation of  both animal models of differential astrocytic pathology, 
at the ICVS will allow further studies in our lab. Despite our interesting results additional 
studies are required to help the elucidation of the mechanisms involved, such as using 
electrophysiological and neurochemical techniques to understand how brain dynamic is 
altered, either in healthy or in pathological states.
v
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RESUMO
Desde há 150 anos, quando surgiu o conceito de “glia”, que o conhecimento das funções 
das células da glia, especialmente dos astrócitos, tem vindo a evoluir drasticamente. Estas 
células em forma de estrela e sem axónios, não só participam no metabolismo de cérebro 
como também contribuem para uma boa actividade neuronal, modelando até a actividade 
sináptica e o fluxo de neurotransmissores. Por fazerem parte da “sinapse tripartida”, 
exibirem uma forma de excitabilidade - baseada em elevações de Ca2+ intracelulares - e 
realizarem gliotransmissão, os astrócitos têm recebido a relevância que levanta a questão de 
que tais células poderão ter maiores implicações nas funções cerebrais. Contudo, estas 
características notáveis bem como a sua influência na modulação do comportamento não 
estão ainda clarificadas. Por isso, na tentativa de contribuir para o progresso do nosso 
conhecimento acerca da função destas células no cérebro, decidimos investigar a componente 
astrocítica nas interacções neurónio-astrócito no contexto das funções cognitivas complexas 
dependentes do córtex pré-frontal, analisando a performance comportamental de dois 
modelos animais de patologia astrocítica: um modelo de rato na qual provocámos a ablação 
de astrócitos no córtex pré-frontal medial, através de injecções bilaterais intracranianas da 
gliotoxina L-α-aminoadipato; e um modelo genético em ratinho, dnSNARE, que exibe um 
bloqueio condicional da libertação vesicular de gliotransmissores nos astrócitos.
Da análise comportamental do modelo de rato, concluímos que a ablação de astrócitos no 
córtex pré-frontal medial afecta o attentional set-shifting, a memória de trabalho e a 
aprendizagem reversa. A análise microscópica de secções de cérebro dos ratos injectados com 
a gliotoxina revelou que as regiões de ablação astrocítica estavam confinadas ao córtex pré-
límbico e córtex cingulado, onde a população neuronal não estava afectada. Uma 
caracterização mais extensiva do modelo de ratinhos dnSNARE revelou que estes animais 
não exibem fenótipo ansioso nem défices de locomoção, mas demostram défices na memória 
de referência espacial (dependente do hipocampo), memória de trabalho melhorada e 
aprendizagem reversa normal (funções dependentes do córtex pré-frontal). Tanto os 
astrócitos como apenas a gliotransmissão aparentam ser cruciais para a computação 
cognitiva e representam uma nova janela de conhecimento que urge ser clarificada em 
termos de vias celulares e mecanismos bioquímicos.
Apesar dos resultados interessantes já obtidos com a implementação já bem sucedida 
destes modelos animais no ICVS, são necessários estudos mais aprofundados para ajudar na 
elucidação dos mecanismos envolvidos. Acreditamos que o recurso a técnicas de 
electrofisiologia e neuroquímica permitirá uma melhor compreensão de como o cérebro está 
alterado, quer em condição de saúde ou doença.
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1. INTRODUCTION
1.1. Astrocytes in the brain
1.1.1. Arousal and evolution of the astrocytic concept
More than 150 years have passed since Rudolf Virchow shared his primordial ideas on the 
brain connective tissue, the “nervenkitt” or nerve-cement which he named “neuroglia” [1]. 
By neuroglia, that he would not believe to contain cellular elements, Rudolf Virchow referred 
to the supportive tissue “which lies between the proper nervous parts, hold them together 
and gives the whole its form in a greater or less degree” [2]. Camillo Golgi did not linger to 
establish the cellular nature of neuroglia [3, 4] and incredibly, this division between nerve 
elements and supportive tissue still persists to a large degree in the convictions of many 
neuroscientists [5]. Later in 1893, Michael von Lenhossek proposed the term “astrocyte”, 
further categorised in fibrous or protoplasmatic, located in white and grey matter, 
respectively [6, 7]. These studies were followed by Santiago Ramón y Cajal who further 
characterised astrocytes in brain tissue and anticipated that these cells should interact closely 
with neurons [8]. In addition to astrocytes oligodendrocytes and microglia, the other non-
neural cells, were also included into the neuroglia concept by Pio del Rio-Hortega [9-11].
The concept of neuroglia (also termed glia) is now more than 150 years-old. However, our 
knowledge on the diversity and features of glial cells, especially astrocytes, has been 
dramatically changing. Despite many years of research that led to the arousal of new 
concepts attributing new roles to glial cells in brain function, their whole range of actions in 
the nervous system is still far from understood [5]. The first attributed role to glial cells, 
presented by the filing concept [2, 12]  had a simple connotation because neuroglia was given 
a passive role as an element that fills “space not occupied by neurons”. Concerning the 
Virchow’s idea that the neuroglia holds nervous elements “together and gives the whole its 
form”, it was already proven that the architecture of the grey matter is defined by the 
astrocytes: protoplasmatic astrocytes occupy a certain territory and canton grey matter 
covering all neuronal elements within that domain [13, 14]. Moreover, astrocytes have been 
considered a homogenous cell population with a distinctive star-shaped morphology due to 
the numerous processes that extend to neurons and blood vessels, and that contain 
intermediate filaments (glial fibrils) [15].
 Despite the fact that astrocytes lack axons and are not capable of generating actions 
potentials, several crucial functions have been attributed to these glial cells, including the 
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maintenance of the neuronal activity through extracellular homeostasis of potassium (K+) 
and hydrogen (H+) ions [16], maturation, survival during development and nutrient supply 
for neurons, release of growth factors, neurotransmitters uptake from the synaptic cleft, 
among others. Even though these functions are well-accepted, neuroscientists still believed 
that there was  much more to be clarified [15].
1.1.2. Astroglia in brain metabolism
Golgi suggested that the purpose of astrocytes was to provide an environment suitable for 
neuronal function. The complex ultrastructure of astrocytes, makes them capable of being 
actively involved in neurotransmitter homeostasis [14, 17-20]. As a matter of fact, it is already 
recognised that astrocytes take up glutamate from the synaptic cleft and metabolise it into 
glutamine, via glutamine synthetase [21, 22], that is then given back to neurons for de novo 
synthesis of glutamate.
 Besides buffering glutamate, astrocytes are also able to bridge the nutrient passage from 
blood to neurons - fig. 1.1. In fact, astrocytes present specialised processes, named endfeet, 
that project to the brain vasculature ensheathing 
the blood vessel walls [23, 24]. This astrocytic 
endfeet location at the capillaries combined with 
the abundant expression of the glucose 
transporter GLUT1 [25], create the perfect 
conditions for astrocytes to access glucose supply 
from blood. However, the flow of energetic 
substrates is not that straight forward. Another 
two substrates, glycogen and lactate are involved 
in the astrocytic regulation of neuronal metabolic 
activity. The synthesis of glycogen may occur as 
a n a l t e r n a t i v e o f g l u c o s e - 6 - p h o s p h a t e 
metabolisation, as a part of the glycogen-shunt 
[26, 27]. Apparently, there is an interdependence 
of glycogen-shunt activity and glycolysis that 
plays an important role in the supply of energy 
for the maintenance of glutamatergic activity [26, 
28]. As reviewed by Brown and Ransom [29], upon increasing brain activation, when the 
immediate supply of neuronal glucose is depleted, glycogen metabolism can provide a rapid 
energy source that rate-limited the step of glucose phosphorylation via hexokinase. Equally 
Figure 1.1. Astrocytes endfeet connecting 
brain capillaries to neurons to bridge the 
nutrient passage from blood [23].
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important is the lactate as an oxidative substrate for energy metabolism, once it is generated 
in astrocytes during glutamate-glutamine cycle as consequence glutamate amidation [30, 31]. 
Because of these findings, a model coupling neuronal activation and glucose utilisation was 
proposed: the astrocyte-neuron lactate shuffle hypothesis [31]. Although research on brain 
metabolic pathways has been controversial, it is important to recognise that upon different 
conditions neurons may rely on glucose, glycogen or lactate to support brain function, as 
these energetic pathways are not mutually exclusive [15].
1.1.3. Modulation of the synaptic transmission: the tripartite synapse
The emerging of astrocyte-neuron interaction biology has been changing our perspective 
on the physiology of the nervous system. In fact, the classically accepted paradigm that brain 
function results exclusively from the neuronal activity is being challenged by recent findings, 
which rather strongly suggest that brain function arises from the concerted activity and 
crosstalk between neurons and astrocytes. In that context, the concept of “tripartite synapse” 
was proposed to conceptualise the occurrence of bidirectional communication between 
neurons and astrocytes [32]: neurotransmitters released from the presynaptic terminals of 
neurons can activate not only receptors on postsynaptic elements, but also on neighbouring 
astrocytes which in turn signal back to 
neurons modula t ing the synapt i c 
transmission  [33, 34] - fig 1.2. More 
precisely, the cellular mechanisms that 
underlie the tripartite synapse concept are: 
(1) Neurotransmitters, such as glutamate, 
released from the presynaptic terminals of 
neurons can activate receptors on 
neighbouring astrocytes through the 
partial bounding to the metabotropic 
glutamate receptors (mGluR); (2) this 
activation leads to the production of 
inositol (1, 4, 5)-triphosphate (IP3) and 
release on calcium ions (Ca2+) from the 
endoplasmatic reticulum to the cytoplasm 
of astrocytes; (3) these increases in 
intracellular Ca2+ concentration- a form of 
astrocytic excitability- are transmitted to 
F i g u r e 1 . 2 .  T h e t r i p a r t i t e s y n a p s e . 
Neurotransmitters (Nt) released in the synaptic 
cleft activate surrounding astrocytes that respond 
with Ca2+ elevations , leading to the modulation of 
the synaptic activity through the release of 
gliotransmitters (Gt).  Adapted from Perea et al 
[34]. 
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neighbour astrocytes as intercellular calcium waves, through gap junctions between 
astrocytes, and ATP, as diffusible messenger of Ca2+ to non-contiguous astrocytes [35, 36]; (4) 
the astrocytic excitability results in the release of gliotransmitters, including glutamate and 
ATP to the extracellular space; (5) the gliotransmitter release feeds back onto pre- and 
postsynaptic terminals culminating in the modulation of the synaptic activity. [37-41]. This 
model of tripartite synapse emphasises the fact that astrocytes are able to sense neuronal 
activity, considering that intra- and intercellular waves of Ca2+ are generated by neuronal 
signals [40, 42].
1.1.4. Integration of neuron-glia circuits: from gap junctions to gliotransmission
Gap junctions are key components on this remarkable feature of astrocytic excitability, 
and are thought to play a crucial role in the integration of neuronal-glial circuits. Indeed, 
most gap junctions in the brain occur in glial cells, and in particular in astrocytes, with a very 
high coupling strength. That astroglial coupling intensity confers a functional astrocytic 
syncytium, that not only forms a metabolic network that can provide energy supply to active 
neurons, but also implies high coordination in astroglial responses so synaptic events [41] - 
fig 1.3.
Intercellular Ca2+ waves are a form of astrocyte signalling that not only occurs in response 
to neuronal activity, but may also appear spontaneously. Even so, they are believed to 
Figure 1.3.  Modulation pathways of the synaptic transmission mediated by gap junctions. Either 
between astrocytes (1) or processes of the same cell (2), gap junctions facilitate the passage of ions, 
second messengers and nutrients. Synaptic activity (3) causes the production of IP3 (4,  grey) and the 
release of Ca2+ (4, green) and the astrocytic excitability is transmitted through gap junctions to the 
neighbor astrocytes as calcium wave. Gliotransmission occurs as  soon as the calcium wave is spread 
to the closest astrocyte in contact with a synapse, and culminates in the modulation of the synaptic 
activity (5). Adapted from Parpura et al [41].
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provide a modulation pathway between domains of separate neurons [41]. That is because a 
single astrocyte can contact over one hundred thousand synapses, yet in a way that 
individual astrocytes occupy distinct and non-overlapping domains in the brain [13, 43]. 
Here arises the evidence that astrocytes respond to neuronal domains defined by them and 
not to individual neurons.
The bidirectional communication between neurons and astrocytes frequently involves 
modulation of synaptic transmission (by tripartite synapse) and plasticity (through dynamic 
GFAP expression upon different physiological conditions, such as synaptic receptor 
activation [44], and secondary messengers, like Ca2+ [45]) [32, 37, 46, 47]. The process by 
which astrocytes communicate with surrounding cells by the release of transmitters is called 
gliotransmission [48]. Those heterocellular signalling events in astrocytes often imply 
regulated exocytosis [49, 50], a process that requires vesicles containing a chemical 
transmitter or a blend of them. The secretion of gliotransmitters to the extracellular space 
occurs by the fusion of the vesicular and plasma membranes, upon a membrane merger. 
Once exocyted, gliotransmitters can exert paracrine function, on adjacent cells, or autocrine 
function, on the cell which secreted them [51]. Moreover, gliotransmitters have been reported 
to act pre- and/or postsynaptically, modulating the synaptic transmission in a transient or 
long-lasting manner [41]. What determines the regulation of exocytosis is the increase of 
cytosolic [Ca2+] that, in the case of astrocytes appears to be slower than in neurons [51]. 
Exocytotic vesicles released from astrocytes were described to contain diverse chemical 
transmitters, such as glutamate, D-serine, ATP, adenosine, GABA, tumor necrosis factor α 
(TNFα), prostaglandins, proteins and peptides that can influence neuronal and synaptic 
physiology [52], blood flow, the permeability of the blood brain barrier and also provide 
metabolic support [5, 15, 34]. Glutamate is synthesised de  novo in astrocytes as a by-product 
of Krebs cycle [21, 53]; D-serine is generated through the stereoisomeric conversion from L-
serine by racemase, an enzyme found in astrocytes [54-56] ; ATP production results from 
aerobic respiration and, as stated above, can mediate intercellular signalling through 
purinergic receptors; but it is more frequent the hydrolysis of ATP by membrane-bound ecto-
nucleotidases to adenosine-diphosphate so that adenosine can act on diverse plasma 
membrane receptors [57]. 
The synaptic transmission causes also the activation of strategically positioned ion flux 
pathways in astroglial perisynaptic processes. Upon activation through the release of ATP 
and/or glutamate, the ionotropic (P2X) and metabotropic receptors (α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid, AMPA, and N-Methyl-D-aspartic acid, NMDA, receptors), 
glutamate transporters and sodium/calcium exchanger (NCX) [58-62] act in a concerted 
manner resulting in the modulation of the synaptic transmission and plasticity by affecting 
the time kinetics of glutamate removal from the synaptic cleft [41]. 
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The sources of Ca2+ necessary for gliotransmission in astrocytes are diverse and complex. 
As a matter of fact there are multiple molecular entities acting to provide Ca2+ to drive Ca2+ -
dependent regulated exocytosis. Calcium ions can be delivered from: (1) the ER lumen to the 
cytosol through IP3- and ryanodine-sensitive receptors that serve as channels [63]; (2) 
through plasmallemal channels, across the astrocytic plasma membrane - in a process named 
store-operated Ca2+ entry (SOCE) [64, 65]-, ligand- and voltage-gated Ca2+ channels (VGCC) 
[66], and NCXs [67, 68] at the plasma membrane that mediate Ca2+ entry from the 
extracellular space to the cytosol, when ER Ca2+ is depleted; (3) mitochondrial matrix, as free 
Ca2+ exits through the mitochondrial NCX and transient openings of the mitochondrial 
permeability transition pore to the cytosol [69]. 
Recent findings demonstrated that gliotransmission can be modulated downstream to 
Ca2+ waves generation, most likely at the secretory machinery level, as observed in the case 
of  glutamatergic output from astrocytes [70]. In fact, astrocytes express exocytotic secretory 
machinery proteins, specially the N-ethylmaleimide-sensitive factor attachment protein 
receptor (SNARE) complex, composed of: synaptobrevin 2- also called vesicle-associated 
membrane protein 2 (VAMP 2)- and its homologue cellubrevin - also called vesicle-associated 
membrane protein 3 (VAMP 3); syntaxins 1, 2 and 4; and synaptossome-associated protein of 
23kDa  (SNAP-23) [71, 72] - fig. 1.4.
Altogether, these astrocytic features allow direct or indirect interference with neural 
communication. Many reports (see section 1.1.3) have shown that astrocytes are able to 
modulate synaptic function, leading to and interference of the information processing at the 
network level, and consecutively in the network-output generation. Therefore it is highly 
predictable that astrocytes play a role in construction of behaviour outputs of a specific brain 
region. This aspect is relevant both in health and pathological states.
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complexity of Ca2+ sources using an example of exocytotic
glutamate release, since it has been studied in most details.
Hence, the majority of cytosolic Ca2+ necessary for astrocytic
glutamate release originates from the ER store as determined
using a blocker of ER-specific Ca2+-ATPases (Araque et al.
1998; Bezzi et al. 1998; Innocenti et al. 2000; Hua et al.
2004; Montana et al. 2004); based on further pharmacolog-
ical evidence both inositol 1,4,5-trisphosphate (InsP3)- and
ryanodine-sensitive receptors serve as channels for delivery
of Ca2+ from the ER lumen to the cytosol (Hua et al. 2004)
(Fig. 4). It should be noted, however, that the functionality of
ryanodine receptors in astrocytes in situ is still debated (Beck
et al. 2004).
The Ca2+ entry across the astrocytic plasma membrane
into to the cytosol eventually represents the source of this ion
for (re)filling of the ER Ca2+ store. This can occur via store-
operated Ca2+ entry. Plasmallemal channels mediating this
event become activated when ER Ca2+ is depleted (Takem-
ura and Putney 1989; Golovina 2005). In particular, the
canonical transient receptor potential 1 protein containing
channels contribute to Ca2+-dependent glutamate release
from astrocytes (Malarkey et al. 2008) (Fig. 4).
In addition to store-operated Ca2+ entry, Ca2+ entry from
the ECS to the cytosol can be mediated by plasma membrane
voltage- and ligand-gated Ca2+ channels. Astrocytes in acute
slices from ventrobasal thalamus showed intrinsic cytosolic
Ca2+ oscillations, which lead to glutamate release (Parri et al.
2001); these oscillations dually draw Ca2+ from the ER store
and the ECS by the Ca2+ entry via voltage-gated Ca2+
channels. Whether the activation of astrocytic ionotropic
transmitter receptors, which leads to cytosolic Ca2+ influx
(reviewed in Lalo et al. 2011a), plays a role in exocytotic
gliotransmission remains to be determined. Another pathway
for Ca2+ entry across the plasma membrane into the
astrocytic cytosol is offered by NCXs operating in the
reverse mode (Kirischuk et al. 1997; Rojas et al. 2008).
Resulting cytosolic Ca2+ increases can cause exocytotic
glutamate release from astrocytes (Paluzzi et al. 2007; Reyes
and Parpura 2009; Reyes et al. 2012).
Mitochondria represent a source/sink of intracellular Ca2+
which can modulate the magnitude of glutamatergic exocy-
tosis in astrocytes (Reyes and Parpura 2008; Reyes et al.
2011). At elevated cytosolic Ca2+ levels, these organelles
take up Ca2+ into the matrix via Ca2+ uniporter. As the
cytosolic Ca2+ declines, free Ca2+ exits the matrix through
the mitochondrial Na+/Ca2+ exchanger as well as via
transient openings of the mitochondrial permeability transi-
tion pore. Indeed, the resulting buffering of cytosolic Ca2+
levels, caused by activity of these mitochondrial proteins,
reflects in modulation of the magnitude of exocytotic
glutamate release from astrocytes (Reyes and Parpura
2008). The contribution of cytosolic proteins that can buffer
Ca2+ and buffering capacities of the nucleus in such
modulation remains elusive at the moment.
Taken together, a concerted effort of various molecular
entities located at the plasma membrane, the ER and
mitochondria regulate cytosolic Ca2+ levels which in turn
drive Ca2+-dependent regulated exocytosis. Interestingly,
there could be additional levels of modulation of this process.
It has been demonstrated that cytosolic glutamate concen-
trations as well as the availably of vesicular glutamate
transporter (VGLUT) 3, that mediates packing of this
gliotransmitter into vesicles (see below), can affect the
magnitude of exocytotic release (Ni and Parpura 2009).
Furthermore, there has been demonstration of the immuno-
phillin-mediated enhancement of the glutamatergic output
from astrocytes, which had been attributed to a downstream
of Ca2+ modulation, likely at the level of secretory machinery
(Reyes et al. 2011).
Indeed, astrocytes express proteins of the exocytotic
secretory machinery, in particular the soluble N-ethyl
maleimide-sensitive fusion protein attachment protein
Fig. 4 Ca2+- dependent vesicular release of gliotransmitters from
astrocytes. The sources of Ca2+ for cytosolic Ca2+ increase are: the
endoplasmic reticulum (ER) and the extracellular space (ECS).
Cytosolic Ca2+ accumulation could be caused by the entry of Ca2+
from the ER store that possess inositol 1,4,5 trisphospate and ry-
anodine receptors. Store specific Ca2+-ATPase fills these stores with
Ca2+. Ultimately, this (re)filling requires Ca2+ entry from the ECS
through store-operated Ca2+ entry. Additional Ca2+ entry from the ECS
to the cytosol can be mediated by plasma membrane voltage -gated
Ca2+ channels and Na+/Ca2+ exchangers, the latter operating in the
reverse mode. Mitochondria represent a source/sink of cytosolic Ca2+.
Mitochondrial Ca2+ uptake from the cytosol to its matrix is mediated by
the Ca2+ uniporter. Free Ca2+ exits the mitochondrial matrix through
the Na+/Ca2+ exchanger and also by brief openings of the mitochon-
drial permeability transition pore. Increase in cytosolic Ca2+ is suffi-
cient and necessary to cause vesicular fusions and release of
gliotransmitters (GT). This process requires the activity of the ternary
SNARE complex consisting of synaptobrevin 2 and/or cellubrevin lo-
cated at vesicular membrane, and the binary cis complex pre-formed
at the plasma membrane and composed of syntaxin (shown in an
open form) and synaptosome-associated protein of 23 kDa. Astrocytic
vesicles are filled by various vesicular GT transporters, which for this
action utilize the proton gradient generated by the vacuolar type H+-
ATPase. Drawing is not to scale.
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Figure 1.4. Calcium-dependent vesicular release of gliotransmitters from astrocytes: sources of Ca2+ 
and the formation of the SNARE complex necessary for gliotransmission in astrocytes [41]. 
1.2. Astrocytes in brain disorders
Astrocytic structure and protein expression were already shown to be altered in the 
context of brain disorders like depression, Parkinson's disease, Alzheimer’s disease, epilepsy 
and schizophrenia [73-86]. What remains to understand is if astrocytic dysfunction 
constitutes the cause, providing detrimental signals that contribute to the disorder, or the 
consequence, performing a supportive function in the attempt to reverse and prevent the 
disorder. Hence it is important to investigate the contribution of astrocytes to network 
function in order to understand their role in pathophysiological states. Since 
gliotransmission is now known as a modulatory factor of synaptic communication (see 
section 1.1.3) it may be considered an important mechanism underlying pathological 
processes.
Assuming the tripartite nature of central nervous system synapses [32] it is possible that 
the astrocytic dysfunction, compromising the neuronal activity support and/or 
gliotransmission, disturbs synaptic transmission and plasticity or neuronal excitability. These 
events at the cellular level are translated into distortion of brain physiology that lead to 
behavioural abnormalities [38]. Rat models of depression exhibit deceasing levels of GFAP 
expression and 13C-acetate metabolism reflecting glial metabolism [75, 77]; also in rat, glial 
loss in the prefrontal cortex (PFC) is sufficient to induce depressive-like behaviour [76]. In the 
context of epilepsy, GFAP immunoreactivity evidenced astrocytic hypertrophy (reactive 
astrocytosis) and proliferation [78]: in mesial temporal lobe epilepsy, GFAP 
immunoreactivity is increased in a way that might be correlated with seizure frequency [79]. 
Moreover, astrocytic Ca2+ oscillations were observed to increase in frequency in isolated 
brain slice models that exhibit epileptiform activity [80]. However, while enhanced excitatory 
gliotransmission, for example in terms of Ca2+ oscillations and glutamate release, can 
contribute to epileptiform activity and seizures, reduced gliotransmission and D-serine 
release can contribute to schizophrenia. Also contrasting is the decreased GFAP expression in 
tissue isolated from schizophrenic patients [81-83]. In Alzheimer’s disease, increased levels 
of amyloid-β (Aβ) peptides and their subsequent deposition in Aβ  plaques lead to the 
activation of the surrounding microglia and astrocytes that release diverse pro- and anti-
inflammatory mediators resulting in the chronicle parenchymal inflammation in the brain 
[84, 85]. In Parkinson’s disease, and other neurological disorders, occurs an abnormal 
neuronal aggregation of α-synuclein, that is directly transmitted from neurons to astrocytes, 
causing inflammatory responses [86]
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1.3. Astrocytic function in vivo: behaviour and cognition
The discovery that astrocytes respond to neuronal transmitters through Ca2+ elevations 
[87, 88] have boosted the studies on astrocytic function attempting to understand more about 
the implications of these glial cells in brain activity and its output. Initially, the research tools 
limited the scientific progress on this subject, but successive studies have been giving input 
for a new insight into the role of glial in the brain function.
Functional and metabolic studies with toxins targeting selectively astrocytes have 
provided simple approaches to study the effects of astroglial dysfunction. Intracerebral 
injections of the gliotoxin L-α-aminoadipate, caused the disruption of the astrocytic network 
when injected intracerebrally in Long Evans Hooded and Sprague Dawley rats, since it 
irreparably damaged the astrocytes in the vicinity of injections [89]. Using this model of glial 
loss, Banasr and colleagues were able to induce depressive–like behaviour in rats [77].
Additionally, a recent study proved that astrocytes modulate the accumulation of sleep 
pressure and its cognitive consequences. These conclusions were achieved using the 
dnSNARE transgenic mice model that conditionally prevents astrocyte-dependent action on 
pre-synaptic A1 receptors through the conditional blockade of vesicular release. Because 
adenosine is involved in homeostatic drive of sleep following prolonged wakefulness, sleep 
pressure was significantly reduced when dnSNARE transgene was expressed in astrocytes 
[47]. Another study based in the same animal model  followed with the evidence that 
astrocytic-derived ATP acting on A1 receptors via adenosine contributes to the effects of 
sleep deprivation on hippocampal plasticity and hippocampus-dependent memory [90].
Although these studies unveil a putative role of astrocytes in the regulation or modulation 
of behaviour outputs much more in this field should be cleared. By implementing different 
animal models of astrocytic dysfunction we expect to assess the implications of astrocytic 
function in the generation or modulation of cognitive function.
1.4. The prefrontal cortex
In this project we focused in the cognitive function and we focused in the prefrontal 
cortex because (1) it is a region with major relevance for cognitive processes (see section 
1.4.1), (2) it is a large region in the brain, and therefore relatively easy to target for injections 
of pharmacological tools (aminoadipate rat model, see section 3.1.1)
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1.4.1. Cognitive functions of the the prefrontal cortex: learning and memory
The prefrontal cortex (PFC), which is among the most studied regions of the brain, is 
intimately related to the computation of complex cognitive functions. Indeed, various 
cognitive and executive processes have been associated to the PFC, such as working memory, 
decision making, planning and behavioural flexibility, attentional set-shifting and inhibitory 
response control [91, 92]. The PFC has been shown to be implicated in the organisation of 
delayed responses and consequently in working memory function - a memory system 
composed of distinct, but overlapping cognitive processes used for the active maintenance 
and elaboration of task-relevant information, as it involves temporary storage and 
manipulation of information [93]. Functional neuroimaging in brain-damaged humans and 
healthy volunteers have confirmed the role of the PFC in working memory processes [94]. 
Neuropsychological and connectional evidences indicate the homology of the medial 
prefrontal cortex (mPFC) in rats and the dorsolateral prefrontal cortex (dlPFC) in primates. 
[95-98] - fig. 1.5. As the dlPFC in primates, the mPFC in rats is involved in other executive 
functions, besides working memory: temporal organisation of behaviour [99] and attentional 
control in strategy switches [98, 100, 101]. In fact, lesions in the rat mPFC - prelimbic (PrL), 
infralimbic (IL), and with partial damage to the cingulate cortex areas 1 and 2 (Cg1 and Cg2) 
- impair selectively the extradimensional set-shifting [98]. Moreover, the rat mPFC was 
proposed to be important in the representation of an abstract and more hierarchically-
organised memory useful in the decision making, complementing the hippocampus in 
spatial navigation [102]. It is not surprising, since the IL and PrL regions of the PFC, 
constituting the ventral portion of the rat mPFC, are linked to the hippocampus by an axonal 
pathway originated in the subiculum and ventral CA1 [103].
Figure 1.5.  Highlights of the PFC and mPFC, in human brain evidencing the homology of mPFC 
and dlPFC brain regions in rat and human, respectively [92]. A - lateral view of human brain; and B, 
left - sagittal view of rat brain; B, right coronal section at Bregma 3.0. dlPFC mPFCPFC
A
B
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2. AIM OF WORK
The rationale of this project is based in the common accepted idea that specific brain 
regions compute specific tasks and are responsible for specific behavioural outputs. In this 
scope, we believe that affecting the astrocytic function in a brain region, mimicking what 
happens in pathological states [75-85], and measuring the behaviour output of that region we 
would be able to dissect the astrocytic component of  that behaviour output. 
Despite the many years of research carried out so far in the astroglial function in the brain, 
most of theses studies were focused on metabolic and physiologic features and little was 
done in what concerns to behaviour implications, namely in cognitive function, involving 
learning and memory, in the context of altered astrocytic function.
The aim of this work is to implement two animal models whose astrocytes are affected in 
two different manners to allow in vivo study of astrocytic function and its implication in 
behaviour outputs. Hence, (1) to mimic pathologies based on the glial loss we implemented a 
rat model on which astrocytes were ablated through the gliotoxin L-α-aminoadipate; and (2) 
to disclose the role of the exocytotic release of gliotransmitters in cognitive processes, we 
implemented the recently reported genetic mouse model, dnSNARE.
In this project we focused in the cognitive function linked to the prefrontal cortex because 
(1) it is a region with major relevance for cognitive processes (see section 1.4), (2) it is a large 
region in the brain, and thus relatively easy to target for injections of pharmacological tools 
(aminoadipate rat model). By lesioning astrocytes in the mPFC and blocking the 
gliotransmitter release by astrocyte we expect to observe a compromise in learning and 
memory functions mostly dependent on the PFC and therefore dissect the astrocytic 
component in the computation of these tasks. 
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3.  MATERIALS AND METHODS
3.1. Animals and Treatments
Experiments were conducted in accordance with local regulations (European Union 
Directive 86/609/EEC) and National Institutes of Health guidelines on animal care and 
experimentation.
3.1.1. Aminoadipate rat model of astrocytic depletion
Male Wistar-Han rats (Charles River Laboratories, Barcelona, Spain) , ten-weeks-old, were 
housed in groups of two, under standard laboratory conditions (room temperature 22ºC; 
food and water ad libitum; 12h dark/light cycle, lights on at 8:00 AM). One group was 
subjected to pharmacological ablation of astrocytes in the mPFC through a single bilateral 
intracerebral microinjection of the selective astrocytic toxin L-α-aminoadipate (L-α-AA; see 
section 3.1.1.B) - treatment group (AA). As control animals (CON) for the aminoadipate 
pharmacological model, other set of rats received a single bilateral intracerebral 
microinjection of artificial cerebrospinal fluid (aCSF), the vehicle of the aminoadipate 
solution, in the same region, using the same procedure. 
3.1.1.A. Surgical procedure for the establishment of the pharmacological rat model
For the establishment of the aminoadipate pharmacological model, rats were subjected to 
a surgical procedure for the implantation of bilateral cannula guides in the prelimbic region 
of the prefrontal cortex. Animals were deeply anaesthetised with a intraperitoneal (i.p.) mix 
of ketamine (75 mg/kg - Imalgene 1000, Merial) and medetomidine (0,5 mg/kg - Dorbene 
Vet, Pfizer) and bilateral brain cannulas (26 GA, Plastics One) were stereotaxically implanted 
in the prelimbic region of the prefrontal cortex. The coordinates used were: 3.0 mm posterior 
to bregma, ± 0.6 mm lateral to the midline, and 2.5 mm ventral to the skull surface, based on 
the Paxinos and Watson rat brain atlas [104]. This position represents a spot 1 mm above the 
target position, which will be achieved by the internal cannulas, used to inject the solution of 
interest. The fixation of the bilateral cannula guides in the skull was achieved by the 
placement of two screws in anterior and posterior positions to relative to the cannula, and by 
the application of an acrylic resin (Pattern Resin LS, GC) covering both screws and the basal 
portion of the cannula guide pedestal. At the end of the surgical procedure the anaesthesia 
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was reverted with atipamezol, i.p. (2 mg/kg - Antisedan, Pfizer) and animals were housed 
individually to avoid damage of the implant. Animals were allowed to recover from this 
surgical procedure for at least 7 days.
3.1.1.B. Drug preparation and administration
A 124 mM L-α-aminoadipate drug solution was prepared through the solubilisation in 
aCSF as previously described [89], by simply dissolve L-α-aminoadipate (A7275, Sigma-
Aldrich) in aCSF and adjusting the pH to 7.4 in order to help to dissolve the aminoadipate. 
Concerning the drug infusion protocol, rats were first anaesthetised with mix of propofol 
(70 mg/kg - Vetofol, Esteve) and medetomidine (0,2 mg/kg - Dorbene Vet, Pfizer) 
administered intraperitoneally. Such anaesthesia protocol based on Alves et al, 2010 provides 
suitable level of sedation ideal for restraint and non-painful drug infusion [105]. Five 
microliters of AA (620 μmol), or aCSF were administered using 25 μl Hamilton syringes, 
connected to a double internal cannula (that projects 1 mm from the cannula guide)  through 
a polyethylene tubbing, at the constant rate of 0.5 μl/min controlled by an micro-pump 
(53100V, Stoeling). The double internal cannula was slowly withdrawn 5 minutes after 
infusion completion to avoid the displacement of the injected fluid by capillarity. Once this 
procedure was complete, anaesthesia was reverted with atipamezol (1 mg/kg - Antisedan, 
Pfizer) and animals returned to their home-cages. 
As the selective gliotoxin L-α-aminoadipate exerts effect 4 hours following injection [89] 
and the astrocyte ablation effect persists up to 7 days, this drug was infused in the rats brains 
on the day before the behaviour tests. In this way, rats preformed the behaviour tests within 
the window of time of L-α-aminoadipate effect.
3.1.2. Transgenic dominant-negative SNARE mice (dnSNARE) genetic model
For the purpose of this project we obtained the dnSNARE transgenic mice strain from 
Prof. Philip Haydon (Tufts University, Boston) that kindly supplied the founders, and 
implemented the colony at the IVCS. In this strain the SNARE domain of the synaptobrevin 
II (dnSNARE) expression is conditionally suppressed in astrocytes, by means of a “tet-Off” 
expression system. The dnSNARE mice strain was generated by Pascual and colleagues 
[106], by expressing the cytosolic portion of the SNARE domain of synaptobrevin II (amino 
acids 1 to 96) selectively in GFAP-positive astrocytes, which blocks the exocytotic release of 
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gliotransmitters, a process dependent on the formation of SNARE complexes [107]. For that 
purpose, they developed two separate mice lines GFAP.tTA and tetO.dnSNARE that when 
crossed yield dnSNARE mice. The GFAP.tTA mice line contains the astrocyte-specific glial 
fibrillary acidic protein (GFAP) promotor that drives the expression of the tetracycline-
controlled transactivator protein (tTA), while the tetO.dnSNARE mice line contains a SNARE 
domain regulated by a tet operator promotor (tetO) and the reporter gene enhanced green 
fluorescent protein (EGFP) - fig. 3.1.
3.1.2.A. Colony implementation: strain lines and matings
To implement this transgenic mice strain in the ICVS, the two mice lines GFAP.tTA and 
tetO.dnSNARE, were first maintained heterozygous under C57/Blk6 genetic background. 
Mice originated by the backcrosses of those two separate lines were crossed (GFAP.tTA x 
tetO.dnSNARE) to produce dnSNARE mice for experimentation. The double negative and 
single positive offspring were kept as controls. In the GFAP-positive astrocytes of these 
animals the expression of transgenes SNARE, LacZ and EGFP is suppressed by the 
tetracycline doxycycline (Dox). To prevent potential developmental effects of the transgene 
expression, mice were bred and raised until weaning, at three weeks of age, under the action 
of Dox (Sigma, 25 μg/ml in drinking water). Once animals were weaned, Dox administration 
was maintained until 3 weeks prior to the behavioural studies. Transgene-expressing and 
wild type mice were visually indistinguishable [106]. The double negative, single and double 
positive offspring were tested in behaviour paradigms described below (see sections 3.2.2).
Figure 3.1. Schematic representation of GFAP promotor driving the expression of the target gene 
dnSNARE and reporter gene EGFP in astrocytes. Tetracycline doxycycline (Dox) suppresses the 
expression of transgenes by preventing the binding of tTA to tetO. Adapted from  Florian et. al, 2011 
and Halassa et. al, 2009 [40, 90]
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3.1.2.B. Colony management and genotyping
In the context of colony management, the genotyping of the offspring generated by the 
mattings was accomplished by means of polymerase chain reaction (PCR) of DNA extracted 
from mice tails (about 3 mm of the tip). First, the tails were digested in 380 μl of cell lysis 
buffer (0,5 mM Tris, pH 8.0; 10 mM EDTA; 0,5 % SDS)  with 10 μl of proteinase K (15 mg/ml), 
overnight and in a heating block at 55ºC. In the next morning, samples were centrifuged 
during 10 minutes at 13000 rpm and the supernatant was collected. The DNA precipitation 
was achieved b the addiction of 300 μl of isopropanol to the collected supernatant, followed 
by soft shaking of the sample tubes. After additional 10 minutes centrifugation at 13000 rpm, 
the supernatant was discarded, while the pellet was rapidly washed with 100 μl of ethanol 
70%. The tubes containing the DNA sample were then left air drying at the bench for 90 
minutes, after which DNA hydration was attained by the addiction of 50 to 100 μl of elution 
buffer (10 mM Tris, pH 8.0; 1 mM EDTA) and a short vortex. 
The genotyping itself was then carried out by the multiplex PCR technique, on which the 
two pairs of primers, for tTA (tTA forward: 5’- ACT CAG CGC TGT GGG GCA TT - 3’; tTA 
reverse: 5‘ - GGC TGT ACG CGG ACC CAC TT - 3’) and tet.O (tet.O forward: 5’- TGG ATA 
AAG CTC ATT AAT TGT CA - 3’; tet.O reverse: 5‘ - GCG GAT CCA GAC ATG ATA AGA - 3’) 
sequences, were used in the same PCR mixture. The PCRs were performed in a MyCycle 
thermal cycler (Bio-Rad); the composition of the PCR mix and conditions used are 
summarised in the table 3.1. Amplified PCR products were separated on a 1% agarose gel 
prepared in Tris-Acetate-EDTA (TAE) running buffer, stained with ethidium bromide and 
compared to the DNA size marker GeneRuler™ 1kb Plus DNA Ladder, 75-20,000bp 
(#SM1331, Fermentas). Electrophoresis run for 40 minutes at 120V and gel images were 
captured with a transilluminator (Alpha Innotech Corporation, Bio-Rad).
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Table 3.1. PCR conditions used for the amplification of tTA and tet.O sequences.
Reaction mix (20 μl) components
Taq buffer, with KCl (part of #EP0402, Fermentas) 1x
MgCl2 (part of #EP0402, Fermentas) 1.5 mM
dNTP mix (#R0192, Fermentas) 0.2 μM
Primer tTA forward 0.5 μM
Primer tTA reverse 0.5 μM
Primer tet.O forward 0.5 μM
Primer tet.O reverse 0.5 μM
Taq DNA Polymerase (#EP0402, Fermentas) 0.5 U
DMSO 2%
Template DNA 100 ng
Amplification program
Step Temperature (ºC) Duration (sec)
Initial denaturation 94 180
30X
Denaturation 94 45
Annealing 61.2 60
Extension 72 60
Final extension 72 600
3.2. Behaviour Tests
3.2.1. Aminoadipate rat model of astrocytic depletion
The behavioural consequences of astrocyte depletion in the medial prefrontal cortex, 
induced by intracranial injection of L-aminoadipate (see section 3.1.1) were assessed by the 
attentional set-shifting task and by water maze-based tests. These tests were used to measure 
the cognitive performance of animals with astrocytic depletion and the respective controls, 
and are described in detail below.
3.2.1.A. Attentional set-shifting task
To assess the non spatial working memory, the attentional set-shifting and the reversal 
learning of rats subjected to the intracranial bilateral injections of AA we used the attentional 
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set-shifting task (ASST). The protocol of this cognitive test was adapted from the ASST 
paradigm originally described by Birrell and Brown [98]. The task was conducted in a 
custom made black Pexiglass apparatus (60 cm L x 40 cm W x 20 cm H). One third of the 
apparatus was separated by the rest of the area by a removable divider, creating a holding 
area. On the opposite side, two adjacent plastic pots filled with sawdust, separated by a 
vertical divider, were used as digging bowls and their rims were scented with different oil 
essences, producing a lasting odour - fig. 3.2.
 
In each trial the pot associated with the correct answer contained a small food reward 
(Nestle Cheerio ring cut in two parts) buried underneath the digging media, as rats could be 
trained to dig in small bowls filled with sawdust to retrieve food reward [108]. The reward 
was predicted either by an odour in the bowl or by a different texture before reaching the 
bowl. Because this test involves a food reward to correct answers, all animals were food 
restricted (1 h of access to food per day) during the prior 6 days. During this food restriction 
period, 6 Nestle Cheerios were given to the rats per home cage. The task was conducted in a 
room with dim light, controlled by a rheostat. Animals were brought to the test room 15 
minutes before its start, to acclimatise them to those room conditions. 
On the two days before the test animals were acclimatised to the apparatus, with food 
rewards in both digging bowls, for 1 hour each day. On the day 1 of the task animals have to 
discriminate from one stimulus, while on the day 2 of the task the animals are presented with 
2 different dimensions of stimuli, odours or textures and have to learn which stimulus leads 
Figure 3.2. Representation of the ASST 
apparatus. The combinations of stimuli are 
located in one third of the apparatus area 
divided in two sections, where the stimuli 
combinations are presented at each trial. 
The opposite third of apparatus separated 
by a removable divider constitutes a 
holding area where the rat rests between 
trials.
removable divider
digging bowl with 
odour scented rim
stimuli section divider
texture
left right
inter-trial 
holding area
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to the reward. On the day 1 of the task, after 5 minutes of habituation to the apparatus, 
animals were first trained in two stages of simple discrimination (SD): odours (lemon vs. 
vanilla)- SDO- and textures (sandpaper vs. blue plastic)- SDT. The second day of the task 
consisted of compound discrimination of odours- CDO- (papaya vs. eucalyptus and 
cardboard vs. brown plastic), reversal compound discrimination- Rev1; extradimensional 
shift- EDST- (mango vs. lotus and velvet vs. plastic grass); and reversal extradimensional 
shift- Rev2. In the reversal stages, the previous positive stimulus, i.e. associated with the 
reward, became negative - table 3.2. The stages were only completed when the animals 
reached 6 correct consecutive trials- when it is considered that the animal learned to associate 
the positive stimulus to the reward [98]- apart from the first 2 trials, when animals are 
allowed to freely explore the both digging bowls. Stimuli were presented in a random 
sequence of 10 trials (equal to all animals), repeated if necessary - tables 3.3, 3.4 and 3.5. As in 
task day 1, animals were allowed to habituate to the apparatus during 5 minutes.
Once task was completed animals returned to their home cages, remaining at that same 
room until sacrifice.
Table 3.2. Order of discrimination stages, relevant and irrelevant dimensions, and stimuli 
combinations of ASST presented to the animals. Reward associated stimuli are bold and 
minus sign indicates absence of stimulus.
Discrimination Stages
Dimensions Stimuli combinations
Relevant Irrelevant Positive Negative
Odor Simple Discrimination(SDO) Odor - Lemon Vanilla
Texture Simple Discrimination (SDT) Texture - Sandpaper Blue Plastic
Compound Discrimination (CD) Odor Texture Papaya /Eucalyptus Cardboard/Brown Plastic
Reversal Compound Discrimination (Rev1) Odor Texture Papaya /Eucalyptus Cardboard/Brown Plastic
Extradimensional Shift (EDST) Texture Odor Velvet/Plastic Grass Mango/Lotus
Reversal Extradimensional Shift (Rev3) Texture Odor Plastic Grass/Velvet Mango/Lotus
19
Table 3.3. Stimuli combinations and sequence of presentation along 10 trials of the simple 
discrimination, stages on test day one: simple discrimination of odors (SDO) and simple 
discrimination of textures (SDT). Reward associated stimuli are bold and minus sign indicates 
absence of stimulus; the shading highlights the position of the stimulus in the test apparatus.
Stage SDO SDT
Right Left Right Left
Trial Odor Texture Odor Texture Odor Texture Odor Texture
1 Lemon - Vanilla - - Sandpaper - Blue Plastic
2 Vanilla - Lemon - - Sandpaper - Blue Plastic
3 Lemon - Vanilla - - Blue Plastic - Sandpaper
4 Vanilla - Lemon - - Blue Plastic - Sandpaper
5 Lemon - Vanilla - - Sandpaper - Blue Plastic
6 Vanilla - Lemon - - Blue Plastic - Sandpaper
7 Vanilla - Lemon - - Blue Plastic - Sandpaper
8 Vanilla - Lemon - - Sandpaper - Blue Plastic
9 Lemon - Vanilla - - Sandpaper - Blue Plastic
10 Lemon - Vanilla - - Blue Plastic - Sandpaper
Reward: Lemon Reward: Sandpaper
Table 3.4. Stimuli combinations and sequence of presentation along 10 trials of the test first 
compound discrimination and its reversal stages:  compound discrimination of odors (CDO) and 
reversal stage one (Rev1). Reward associated stimuli are bold; the shading highlights the position 
of the stimulus in the test apparatus.
Stage CDO Rev1
Right Left Right Left
Trial Odor Texture Odor Texture Odor Texture Odor Texture
1 Papaya Brown Plastic Eucalyptus Cardboard Papaya Cardboard Eucalyptus Brown Plastic
2 Eucalyptus Brown Plastic Papaya Cardboard Papaya Cardboard Eucalyptus Brown Plastic
3 Eucalyptus Cardboard Papaya Brown Plastic Papaya Cardboard Eucalyptus Brown Plastic
4 Eucalyptus Cardboard Papaya Brown Plastic Eucalyptus Cardboard Papaya Brown Plastic
5 Papaya Cardboard Eucalyptus Brown Plastic Eucalyptus Brown Plastic Papaya Cardboard
6 Papaya Brown Plastic Eucalyptus Cardboard Papaya Brown Plastic Eucalyptus Cardboard
7 Eucalyptus Brown Plastic Papaya Cardboard Eucalyptus Brown Plastic Papaya Cardboard
8 Eucalyptus Cardboard Papaya Brown Plastic Eucalyptus Cardboard Papaya Brown Plastic
9 Papaya Cardboard Eucalyptus Brown Plastic Papaya Brown Plastic Eucalyptus Cardboard
10 Papaya Cardboard Eucalyptus Brown Plastic Eucalyptus Brown Plastic Papaya Cardboard
Reward: Papaya Reward: Eucalyptus
20
Table 3.5.  Stimuli combinations and sequence of presentation along 10 trials of the test second 
compound discrimination and its reversal stages:  extradimensional shift- discrimination of 
textures- (EDST) and reversal stage two (Rev2). Reward associated stimuli are bold; the shading 
highlights the position of the stimulus in the test apparatus.
Stage EDST Rev2
Right Left Right Left
Trial Odor Texture Odor Texture Odor Texture Odor Texture
1 Lotus Velvet Mango Plastic Grass Lotus Velvet Mango Plastic Grass
2 Mango Plastic Grass Lotus Velvet Mango Velvet Lotus Plastic Grass
3 Mango Velvet Lotus Plastic Grass Lotus Velvet Mango Plastic Grass
4 Mango Velvet Lotus Plastic Grass Lotus Plastic Grass Mango Velvet
5 Lotus Plastic Grass Mango Velvet Lotus Velvet Mango Plastic Grass
6 Lotus Plastic Grass Mango Velvet Mango Velvet Lotus Plastic Grass
7 Mango Plastic Grass Lotus Velvet Mango Plastic Grass Lotus Velvet
8 Mango Plastic Grass Lotus Velvet Mango Plastic Grass Lotus Velvet
9 Lotus Velvet Mango Plastic Grass Mango Velvet Lotus Plastic Grass
10 Lotus Velvet Mango Plastic Grass Lotus Plastic Grass Mango Velvet
Reward: Velvet Reward: Plastic Grass
3.2.1.B. Water maze tests
The tests were conduced in a circular black pool (170 cm diameter) filled with water at 
22ºC to a depth of 34 cm in a room with extrinsic clues (triangle, square, cross and horizontal 
stripes) and rheostat controlled dim light. Imaginary lines were dividing the tank in four 
quadrants, one of which containing a submerged cylindrical plexiglass platform (12 cm, 32 
cm high) covered with black plastic to remain un undistinguishable from the pool - fig. 3.3 . 
Rats behavioural data was collected by a video camera fixed in the ceiling and connected to a 
video-tracking system (Viewpoint, Champagne au mont d’or, France). The water maze tests 
consisted of a six days protocol and involved four distinct tasks. In general, the tasks are 
composed by four trials with the maximum duration of 2 minutes. At the beginning of each 
trial rats were placed in the water facing the maze wall and oriented to one of the four 
extrinsic clues, i. e., in one of the four imaginary quadrants (Q1, Q2, Q3 and Q4). The trial 
was only complete when the animal escaped to the platform or in case the animal did not 
reach the platform two minutes after the beginning of the trial. In that case, animals were 
gently guided to the platform. After twenty seconds on the platform, rats were then taken 
out of the maze to start a new trial. At the end of each trial the distance swam and escape 
latency were registered. In the cases when rats did not find the platform, the registered 
escape latency was 2 minutes (120 seconds) .
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Working memory task (WMT): The first of the paradigms used was the working memory 
task, a variant of the spatial reference memory test [109] to assess this PFC function. The 
purpose of this task is to assess  the ability of rats to learn the location of the hidden platform 
and to retain this information online during the four consecutive trials. Usually, the working 
memory task consists of four days. At each day the platform location is the same in all four 
trials, but varies from day to day using a different quadrant per day [99]. Considering that 
the aminoadipate model of astrocytic dysfunction has a window of time of only seven days 
to perform behaviour tests we decided to remove one of the days from this task just to be 
sure that animals were performing the tests with the aminoadipate effect-window. We chose 
to remove the day on which the first trial of the task is started in the same quadrant of the 
platform. Average escape latencies and distance swam in each trial along the three days of 
this task were considered as working memory test results, since faster animals display better 
working memory performance.
Spatial reference memory task (RMT): following the working memory task (days 1-3) 
animals performed the reference memory task, which is hippocampus-dependent [109], until 
day 5 (the first day of working memory task was also considered as the first day of reference 
memory task and the last day of working memory task was also considered as the second 
day of the reference memory task). On this task, the platform was kept in the same quadrant 
as test in day 3 so that we could assess the ability of the animals to learn the position of the 
platform along the days. The escape latencies and distance swam output of this test were 
analysed as means from the four trials of each day and interpreted as reference memory 
performances. Animals with shorter latencies or distance swam display better reference 
memory. 
Reversal learning task (RLT): On day 6, the animals performed the reversal learning task, 
which is prefrontal cortex-dependent [110], on which the platform is placed in the opposite 
quadrant of the previous location learnt in the reference memory task. The reversal learning 
of the rats was evaluated through the analysis of the distance swam and time spent in each 
Figure 3.3.  Representation of the water maze tests apparatus, 
prepared for rats with the extrinsic clues (triangle, square, cross 
and horizontal stripes) and the platform (P).  Four imaginary 
quadrants (Q1, Q2, Q3 and Q4) divided the pool.
22
quadrant as a mean of the four trials. An extra trial, probe trial, in which the platform is 
removed from the tank, was performed to confirm that the reversal learning was correctly 
executed [109]. During the 2 minutes of this probe trial the distance swam and time spent in 
each quadrant were measured. A good performance in the reversal learning consisted of 
higher percentage of time or distance swam in the new quadrant, when compared to the old 
quadrant.
The timeline followed in this cognitive test with the rat model of astrocytic ablation is 
depicted in table 3.6.
Table 3.6. Timeline followed in the water maze tests used for rat models of astrocytic ablation.
Task WMT 1 / 
RMT 1
WMT 2 WMT 3 / 
RMT 2
RMT 3 RMT 4 RLT + Probe 
Day 1 2 3 4 5 6
3.2.2. dnSNARE mice model of impaired vesicular release in astrocytes
The dnSNARE mice were recently created [106] and the behaviour phenotype of this mice 
strain is still poorly tested [40] (see chapter 5). Therefore we performed primarily the open 
field test and the elevated plus maze to assess if these animals possess any lack of 
exploratory motivation, locomotion difficulties or anxiety that would mislead us in tests that 
measure cognition. Then the animals were tested in water maze-based paradigms and in the 
continuous spontaneous alternation test to assess cognitive function. Details on the specific 
tests are given below.
3.2.2.A. Elevated Plus Maze (EPM)
The paradigm of this test was established by Hanldy and Mithani [111] basing in the 
observations that elevated open alleys evoke greater avoidance responses than closed alleys 
in rat [112] and was already validated also for the use in mice [113]. dnSNARE mice anxious 
phenotype was assessed in a “plus“ shaped maze (ENV-560, Med Associates, Inc.) consisting 
in two opposite open arms (50.8 cm L x 10.2 cm W x 40.6 cm H) and other opposite closed 
arms (50.8 cm L x 10.2 cm W x 40.6 cm H), elevated 72.4 cm above the floor. During the 5 
days prior to the test, mice were handled once a day for 1 minute each. Mice exploratory 
activity in the EPM was individually recorded during 5 minutes and the time spent in open 
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arms, hub (arms junction area) and the number of entrances and explorations in each section 
were analysed through a system of infrared photo-beams using a video tracking interface 
(SOF-842, Med Associates, Inc.). The test was performed under bright white light. The maze 
was carefully cleaned, between each animal, with 10% ethanol to avoid traces to be left from 
one animal to another. The collected data was used to calculate the ratio of time spent in 
open arms over time in closed arms and the percentage of open arms entries, being time 
presented as percentage over total duration of the trial. 
3.2.2.B. Open field test (OF)
In order to assess the spontaneous locomotor activity, exploratory behaviour and 
anxiogenic-like behaviour (thigmotaxis) [114-116] in dnSNARE mice, the OF test was used. 
Mice were handled for 1 minute each day during 5 consecutive days before the test. The test 
was conducted in a Plexiglass box enclosing a white arena (43.2 cm L x 43.2 cm W x 30.5 cm 
H) with a centre zone delimited with an imaginary perimeter set at 10 cm from the sides of 
the arena (ENV-515-16, Med Associates, Inc.). Total distance moved (length of the path), 
movement speed, number of rearings and time spent in the centre zone were analysed 
through the 16 infrared photo-beams using Activity Monitor video tracking system 
(SOR-811, Med Associates, Inc.). At the beginning of the test session, mice were placed 
individually into the middle of the OF arena and let explore during 5 minutes. Between each 
animal, the arena was carefully cleaned with 10% ethanol to avoid traces to be left from one 
animal to another.
3.2.2.C. Water maze tests
The water maze tests were conducted in a circular white pool (170 cm diameter) filled 
with water at 22ºC to a depth of 32 cm in the same room as rats water maze  tests with the 
extrinsic clues (triangle, square, cross and horizontal stripes) and rheostat controlled dim 
light, similarly to the one used to test the rat animal model. Imaginary lines were dividing 
the tank in four quadrants, one of which containing a cylindrical plexiglass platform (8 cm, 
30 cm high) - fig 3.4. Mice behaviour data was collected with a video camera fixed in the 
ceiling and connected to a video-tracking system (Viewpoint, Champagne au mont d’or, 
France). The water maze tests consisted in a five days protocol that involved two distinct 
tasks: reference memory task and reversal task. Similarly to the protocol used for rats water 
maze tests, in general tasks are composed by four trials with the maximum duration of 2 
minutes. At the beginning of each trial mice were placed in the water facing the maze wall 
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and oriented to one of the four extrinsic clues, in one of the four imaginary quadrants (Q1, 
Q2, Q3 and Q4). The trial was complete when the animal escaped to the platform or when 
the escape did not occur within 2 minutes. In that case, mice were gently guided to the 
platform. After twenty seconds on the platform, mice were taken out of the maze to start a 
new trial. At the end of each trial the distance swam and escape latency was registered. In 
the cases when mice did not find the platform, the registered escape latency was 2 minutes 
(120 seconds).
Spatial reference memory task (RMT): mice were tested for its spatial reference memory 
with the hippocampus-dependent reference memory task [109], until day 4. On this task, the 
platform was kept in the same quadrant so that we could assess the ability of mice to learn 
the position of the platform along the four days. The escape latencies and distance swam 
output of this test were analysed as means from the four trials at each day and interpreted as 
reference memory test. Animals with shorter latencies or distance swam display better 
reference memory. 
Reversal learning task (RLT): The PFC function was assessed by the reversal learning 
task on which the platform is placed in the opposite quadrant of the previous location [110], 
similarly to the procedure for rats. The reversal learning of the mice was evaluated through 
the analysis of the distance swam and time spent in each quadrant as a mean of the 
remaining three trials, with a duration of 2 minutes each. A good performance in the reversal 
learning consisted of more percentage of time or distance swam in the new quadrant, when 
compared to the old quadrant.
The timeline followed in this cognitive test  for the mice model of astrocytic dysfunction is 
specified in table 3.7.
Figure 3.4.  Representation of the water maze tests apparatus, 
prepared for mice, with the extrinsic clues (triangle, square, 
cross and horizontal stripes) and the platform (P). Four 
imaginary quadrants (Q1, Q2, Q3 and Q4) divided the pool.
25
Table 3.7. Timeline followed in the water maze tests used for the mice models of astrocytic 
dysfunction.
Task RMT RLT
Day 1 2 3 4 5
3.2.2.D. Continuous spontaneous alternation test
This test, conduced in Y-maze, was used to assess spatial working memory function in 
transgenic dnSNARE mice. The Y-maze apparatus consisted of three costume made white 
Pexiglass closed arms (35 cm L x 5 cm W x 8 cm H), elevated x 120 cm above the floor, based 
on published protocols previously adapted for mice [117, 118]. Each arm is identical, so that 
intra-maze cues were not provided to mice, while they were allowed to see distal spatial 
landmarks (triangle, horizontal stripes and cross). The test was performed by placing each 
mouse in the centre (c) of the three arms of the apparatus and letting the animal to explore 
the maze freely during 5 minutes - fig3.5. A video camera was used to record the movements 
of the animal in the maze. This test is based on innate curiosity  of rodents to explore novel 
areas, which is relies in their working memory. This test presents no negative or positive 
reinforcements, therefore not stressful for the animals. The number and sequence of arm 
entrances was recorded manually. The total of number of arm entrances was used as a 
measure of motivation to explore the maze and locomotor activity. The assessment of  mice 
spatial working memory was given by the percentage of alternations (alternation score, %) 
was calculated, basing on the principle that one alternation was counted when animals 
visited the three different arms consecutively and immediate reentries were discounted (for 
example, 1-3-2; 2-1-3). The assessment of mice spatial working memory was given by the 
percentage of alternations (alternation score, %), being one complete alternation  each time 
the animal visited the three different arms consecutively (immediate reentries were 
discounted). The alternation score was calculated by the number of alternations divided by 
the total possible alternations (number of arms entered minus 2) and multiplied by 100 [117].
Figure 3.5. Representation of the Y maze apparatus. The 3 arms are 
randomly numbered from 1 to 3; c - centre of the Y-maze. 
c
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3.3. Histological procedures
3.3.1. Euthanasia and tissue preparation
One hour after  ASST or water maze tests completion rats were deeply anaesthetised with 
an overdose of ketamine and medetomidine mix, and readily perfused transcardially with 
ice cold paraformaldehyde 4% in PBS (0.1 M, pH 7.4) solution. Brains were then removed 
and placed in the same fixative for 48 hours and then in 30% sucrose in PBS solution (for 
impregnation) until sinking, at 4ºC under agitation. Once sinked, brains were frozen by 
immersion in liquid nitrogen in Neg-50 frozen section medium (Thermo Scientific) and 
stored at -80ºC until sectioning. The tissue obtained represented the lesion of aminoadipate 
at day 3 and day 7 post-injection, whether the animals had performed the ASST or water 
maze-based tests, respectively. 
3.3.2. Immunofluorescent staining of astrocytes and neurons
In order to analyse the histological implications and extension of the lesion caused not 
only by the injection of AA, but also by the mechanical trauma of the bilateral cannula guides 
implantation, we performed the immunofluorescent detection of astrocytes and neurons in 
20 μm thick coronal sections of the PFC cut in a cryostat (Leica CM1900). The 
immunofluorescent procedures were only applied to representative brain sections, selected 
by signs of cannula entry at the brain surface.
For the immunofluorescent detection of neurons an astrocytes,  the procedure started with 
an antigen retrieval step, with citrate buffer (10 mM) during 20 minutes at 100W microwave 
potency. Once cooled, slices were submitted to two rinses of 3 minutes in PBS, followed by 
the overnight incubation with the primary antibodies rabbit polyclonal anti-rat GFAP (1:200, 
DakoCytomation) and mouse polyclonal anti-rat NeuN (1:100, Milipore) in PBS with 0,5% 
Triton X-100 and 10 % fetal bovine serum (FBS). After three rinses of 3 minutes in PBS, 
sections were then incubated with the secondary antibodies Alexa Fluor® 594 goat anti-
rabbit and Alexa Fluor® 488 goat anti-mouse (1:1000, Molecular Probes®) in PBS with 0,5% 
Triton-X, during 90 minutes. Once slices were rinsed again, the cellular nucleic acids were 
indiscriminately labelled through 10 minutes incubation with Dapi antibody (1:1000, 
Invitrogen). A final series of 3 minutes rinses in PBS, slides were mounted with coverslips in 
Immu-mount (Thermo Scientific Shandon) mounting media.
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3.3.3. Microscopic analysis
3.3.3.A. Identification of lesion sites
The result of the immunofluorescent labelling of astrocytes and neurons in brain sections 
from the animals injected with AA and respective controls was analysed by means of an 
epifluorescence microscope (BX61, Olympus) coupled with a digital camera system (DP70, 
Olympus). The lesion sites were identified through the GFAP immunofluorescence detection 
and using the Cell^P imaging software (Olympus) to capture pictures. The lesion site was 
easily detected in the brains of animals injected with L-Aminoadipate (L-α-AA) by an halo in 
the tissue without GFAP staining in the medial prefrontal cortex - fig. 4.2A. In the brain 
sections from control animals, the site of cannula guide placement was confirmed by the 
physical signs of cannula entry in the brain surface  - fig. 4.2 A a1. The site of injection was 
calculated 1 mm below those marks, as the double internal cannulas projected 1 mm from 
the cannula guides.
Maps of injection site that indicated the lesion localisation were created - fig 4.1. The 
animals where the lesion was located outside the medial prefrontal cortex (mPFC) were 
excluded from the analysis.
3.3.3.B. Stereological analysis of the affected region
To further characterise the lesion caused by the L-α-AA injection in the mPFC, we 
analysed specifically the Cg1, PrL and IL sub-regions, namely by counting the GFAP- and 
NeuN-positive cells to generally estimate the affection of astrocytes and neurons, 
respectively. In order to count the cells, 5 μm spaced z-scan images from the representative 
brain sections selected previously (see section 3.3.3.A) were obtained using a confocal 
microscope (Olympus FV1000, Japan) under a 20X objective. Laser excitation wavelengths 
were set at 405 nm for Dapi, 488 for NeuN and 559 for GFAP secondary antibodies; the 
pinhole was adjusted to 80.0 μm. Each of the mPFC subregions were outlined according to 
the rat brain atlas of Paxinos and Watson [104]. GFAP-positive astrocytes and NeuN-positive 
neurons were counted using ImageJ (http://rsbweb.nih.gov/ij/) with the “Cell counter” 
plugin in the confocal z-stacks projections, obtained in the Simple Confocal Viewer software 
v1.0.1. Because the astrocytic morphology may be confusing due to complex processes tree 
that may overlap with vicinal astrocytes, and fluorescent artefacts may lead to false positives, 
only co-localisations with DAPI were considered for counting in both cell types. In order to 
avoid small fluctuations of fluorescent staining quality from slice to slice, the number of cells 
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counted in the Cg1 and PrL was normalised to the number of cells counted in the IL, a 
vicinal region spared from the surgical procedure and gliotoxin lesion, resulting in a ratio 
that allows comparison between different animals.
3.3.4. Statistical Analysis
Data are expressed through the study as means ± SEM. Statistical analysis was performed 
using the GraphPad Prism 5 software (GraphPad Software, Inc.) for Mac OS X. For the 
analysis of one variable between two groups of animals, Student’s t-test (comparing distance 
travelled, velocity and number of rearings in the OF; the alternation score and the total 
number of arm entrances in the continuous spontaneous alternation between wt and 
dnSNARE mice), or Mann-Whitney’s test (comparing the indexes of learning and reversal of 
CON and AA animals in the ASST) were used. Two-way ANOVA analysis and Bonferroni 
post-hoc tests were applied to compare the GFAP/IL or NeuN/IL cells ration in lesioned and 
non-lesioned sites of brain areas from animals that performed ASST and water maze tests; to 
compare the performance of AA and CON animals along the stages of ASST; to study the 
effect of gender and genotype in distance travelled, velocity and number of rearings in the 
OF and the alternation score and the total number of arm entrances in the continuous 
spontaneous alternation between wt and dnSNARE mice. For the more complexes analysis 
such as studying the group effect in the water maze performance of rats along the trials 
(WMT) and rats and mice along the days (RMT), as well as to study the effect of the 
genotype alone or the genotype and gender in the EPM performance (time spent on, entries 
and explorations on open and closed arms) and time spent by mice in the center of the OF 
arena, two-way repeated measures ANOVA and Bonferroni post-hoc tests were used. At last, 
for studying the performance of rats and mice in the reversal learning and probe tasks of the 
water maze tests, we used multivariate ANOVA (MANOVA) and Bonferroni post-hoc tests. 
The appropriate statistical test is denoted for each experiment in the Results section (see 
chapter 4). The statistical significance of the comparisons for each statistical test was set with 
a confidence interval of 95% (α=0.05).
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4.  RESULTS
4.1. Aminoadipate pharmacological rat model
4.1.1.  Selection of animals and lesion features 
Following the microscopy analysis of the brain sections from animals injected with  L-α-
AA or aCSF, we performed the selection of the animals whose site of injection was within the 
mPFC- fig. 4.1. From the set of animals that performed the ASST, 7 CON and 6 AA animals 
animals were considered for the analysis of the behaviour output, while 6 CON animals and 
8 AA animals were considered for the analysis of the behaviour output from the the animals 
that performed water maze tests. In these animals, the centre of the lesion was localised 
between the medial and dorsal portions of the PrL and Cg1 sub-regions of the medial PFC.
Figure 4.1.  Representation of the sites of brain injections, 4.20 mm to 2.76 mm from Bregma. A - Set 
of animals that performed ASST; B- Set of animals that performed water maze tests, according to the 
Paxinos and Watson rat brain  atlas figures [104].   ●  CON;   ●  AA.
A B
Bregma
4.20 mm
3.72 mm
3.24 mm
3.00 mm
2.76 mm
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The microscopy analysis of the rats brain tissue preparations revealed that the bilateral 
injection of L-α-AA induced astrocyte depletion in the whole range of injection, forming an 
halo within the GFAP staining. Despite of the complete absence of astrocytes, neurons were 
still detectable within the lesioned area - fig 4.2. The ratio of the GFAP positive cells number 
of cells in lesion sites over the the number of cells in non-lesioned sites, at the IL and ventral 
portion of the PrL, illustrates the complete absence of astrocytes in gliotoxin injected subjects. 
(lesion sites, ASST: CON, n=5 and AA, n=5; water maze tests: CON, n=5 and AA, n=5; non-
lesion sites,  ASST: CON, n=5 and AA, n=4; water maze tests: CON, n=5 and AA, n=6). Two 
way ANOVA test pointed out significant differences between the ratio of GFAP positive cells 
in CON and AA subjects, either in animals that performed ASST, at 3 days post-injection, or 
water maze tests, at 7 days post injection (ASST, CON: 1. ± 0.0, AA, 0.0 ± 0.0, t=12.5, p<0.001 - 
fig 4.2 b1; water maze tests, CON: 1.2 ± 0.1, AA, 0.0 ± 0.0, t=6.7, p<0.001 - fig 4.2 c1). 
Regarding the non lesioned regions the of GFAP positive cells ratios did not differ between 
CON and AA animals of the ASST and water maze tests sets (ASST, CON: 1.5 ± 0.1, AA, 1.4 ± 
0.0, t=0.7, p>0.05 - fig. 4.2 b2; water maze tests, CON: 1.4 ± 0.1, AA, 1.4 ± 0.1, t=0.2, p>0.05 - 
fig 4.2 c2). Opposite to what happened with the GFAP immunoreactivity, NeuN stained cells 
were not affected by the L-α-AA injections, as the two-way ANOVA have not evidenced any 
differences between groups in lesioned sites either in ASST or water maze tests set of animals 
(ASST, CON: 1.0 ± 0.1, AA, 1.1 ± 0.1, t=0.4, p>0.05 - fig 4.2 b1; water maze tests, CON: 1.1 ± 
0.1, AA, 0.9 ± 0.2, t=1.2, p>0.05 -  fig 4.2 c1) And as expected, the same was true in non 
lesioned sites (ASST, CON: 1.2 ± 0.4, AA, 1.5 ± 0.1, t=0.3, p>0.05 -fig 4.2 b2; water maze tests, 
CON: 1.6 ± 0.2, AA, 1.4 ± 0.1, t=1.2, p>0.05 - fig 4.2 c2).
4.1.2. Behaviour performance
In order to assess the translation of astrocyte depletion in the behaviour output of the 
prefrontal cortex, animals injected with the gliotoxin L-α-AA and their respective controls 
were tested through the ASST and the water maze based tests.
4.1.2.A. Attentional set-shifting task
The ASST allowed assessing the PFC-dependent functions such as attention, dimensional 
set-shifting and reversal learning [98]. A two-way analysis of variance (two-way ANOVA) of 
the number of trials to criterion (TC) - number of trials needed by each group of animals 
(CON, n=7; AA, n= 6) until acquisition of the rule in each stage - showed that animals with 
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astrocyte depletion in the mPFC (AA) have more difficulty to learn to discriminate stimuli in 
the dimension of textures (SDT: CON 11.7 ± 2.5 TC and AA 31.8 ± 9.3 TC, t= 2.7, p<0.05) and 
to perform reversal learning (Rev1: CON 13.4 ± 2.1 TC and AA 33.5 ± 7.6 TC, t=3.0, p<0.05; 
Rev2: CON 13.3 ± 2.7 TC and AA 41.0 ± 9.9 TC, t=3.8, p<0.01), when compared to controls 
(CON) - fig. 4.3. No differences between groups were observed in the remaining stages (SDO: 
CON 14.6 ± 3.3 TC and AA 20.5 ± 7.5 TC, t=1.1, p>0.05; CDO: CON 15.3 ± 3.3 trials and AA: 
13.3 ± 2.2 TC, t=0.2, p>0.05; EDST: CON 16.4 ± 3.9 TC and AA 11.3 ± 2.0 TC, t=0.70, p>0.05). 
Figure 4.2. Effects of the gliotoxin L-α-AA.  A - intracranial L-α-AA injections cause astrocytic 
ablation denoted by an halo of no GFAP immunoreactivity; a1- brain section from CON animal; white 
arrow denotes the physical damage caused by the cannula placement; a2 -  brain section from AA 
animal evidencing astrocytic ablation in Cg and PrL, detailed in a3; a4 - confocal imaging evidencing 
no astrocytes within the lesioned area, while neurons were not affected . B and C- Ratio of the number 
of cells within lesion sites (Cg1 and ventral portion of PrL) - b1 and c1- over the number of cells in 
non-lesion region (IL) compared to a non-lesioned region - b2 and c2- in animals that performed ASST, 
B and in animals that performed water maze tests, C. *** p<0.001.
A a1 a2 a3 a4
B b1 b2
c1 c2C
33
The index of learning, mean TC from the learning stages (fig. 4.4 A) shows that both groups 
of animals learn similarly how to discriminate new stimuli along the stages of this task 
(CON: 14.5 ± 1.6 TC and AA: 19.8 ± 3.2 TC,  Mann-Whitney U= 279.5, p>0.05). However, the 
index of reversal, mean TC from the reversal stages, points out a striking difference between 
controls and animals depleted of astrocytes in the mPFC - fig 4.4 B (CON: 13.4 ± 1.7 TC; AA 
37.3 ± 6.1 TC, Mann-Whitney U= 11.5, p<0.001) which confirms the performance observed in 
both reversal learning stages (fig. 4.3).
Figure 4.3. Trials to criterion along ASST stages. Rats injected with aCSF (CON) and L-α-AA (AA) 
Data plotted as mean ± SEM.  * p<0.05, ** p<0.01.
Figure 4.4. Indexes of Learning and Reversal.  A - mean trials to criterion in learning stages, Index of 
learning; and B- mean trials to criterion in reversal stages, index of reversal, of rats injected with aCSF 
(CON) and L-α-AA (AA). Data plotted as mean ± SEM. n. s. p>0.05. *** p<0.001.
A B
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4.1.2.B. Water maze based tests
The water maze-based tests allowed assessing spatial working memory (WMT), spatial 
reference memory (RMT) and reversal learning (RLT) [119] in the animals depleted of 
astrocytes and respective controls (CON, n=6; AA, n= 8). The analysis of the WMT learning 
curve (fig. 4.5 A) showed that astrocyte depletion impaired consistently the acquisition 
process (AA, trial 4: 45.2  ±  7.8 s , t=2.6, p<0.05) when compared to control animals which 
showed a typical learning curve along trials (CON, trial 4: 15.3 ± 4.1 s ; p<0.05) [119]. In the 
spatial RMT (fig. 4.5 B) no differences were observed between both groups of animals 
regarding the shape of the learning curves (day 4: CON 16.4 ± 4.4 s and AA 25.5 ± 5.8 s, t=1.0 
p>0.05). It is noteworthy that in the first day of the task, a difference was observed between 
both groups (day 1, CON: 40.4 ± 4.1 s, and AA 65.0 ± 6.8 s, t=2.8, p<0.05), which is a reflex of 
their different performance in the WMT. In the RLT (fig. 4.6 A) the multivariate ANOVA test 
evidenced no differences in the percentage (%) of time spent by CON and AA animals in 
each quadrant. The absence of statistically significant differences in probe test confirms that 
although a tendency for both groups to spend more time in the quadrant where the platform 
was located in the RLT (Q4) is observed, both groups of animals failed to learn the RLT since 
in the probe trial the % time spent in the new quadrant (Q2) does not significantly differ 
from the % time spent in the old quadrant (Q4) (Q2: CON 32.8 ± 2.8 % and AA 34.1 ± 3.9 %; 
Q4: CON 27.6 ± 3.5 % and AA 22.5 ± 3.3 %) and does not differ between groups (Q2: CON 
32.8 ± 2.8 % and AA 34.1 ± 3.9 %, t=0.2, p>0.05 - fig. 4.6 B)
Figure 4.5. Escape latencies (s) in water maze tests. A - Escape latencies (s) in the working memory 
task, WMT; B -Escape latencies (s) in the spatial reference memory task, RMT of rats injected with 
aCSF (CON) and L-α-AA (AA). Data plotted as mean ± SEM. * p<0.05.
A B
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Figure 4.6. Performance of the rats in the reversal learning task, RLT and probe task of the water 
maze tests. A - Percentage of time (%) spent by rats rats injected with aCSF (CON) and L-α-AA (AA) 
in each of the quadrants in the reversal learning task, RLT ; and B - in the the probe task. Dotted line 
represents performance at chance level (25%). Data plotted as mean ± SEM. n. s. p>0.05.
A B
4.2. dnSNARE mice model of impaired vesicular release in astrocytes
After implementation of the dnSNARE colony at the ICVS, 48 animals were generated 
from crossings between heterozygous GFAP.tTA and tetO.dnSNARE mice. In order to avoid 
experimental bias, all animals were blind tested as the genotyping was only performed after 
the behavioural phenotype assessment.
4.2.1. Genotyping and selection of animals
The results from the genotyping are summarised in the figure 4.7 A and B. From the 48 
animals used in the behavioural phenotype assessment 18 were wt (10 female, ♀ and 8 male, 
♂), 8 were dnSNARE (5 ♀ and 3 ♂), 15 were tetO.dnSNARE (5 ♀, and 10 ♂) and 7 were 
GFAP.tTA (4 ♀ and 3 ♂). Only wild type (wt) animals and double mutant animals 
(dnSNARE) were considered for the analysis of the behavioural performance in the different 
tests.
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4.2.2. Behaviour performance
In order to characterise the behavioural phenotype of the dnSNARE mice strain, 48 
animals originated by the mattings between the mice lines GFAP.tTA and tetO.dnSNARE 
were subjected to four behaviour tests: EPM, OF tests, water maze based tests and 
continuous spontaneous alternation task. These tests aimed to assess anxiety, locomotion and 
exploratory behaviour, and cognition (memory and learning) of the dnSNARE animals, 
comparing to their wt littermates.
4.2.2.A. Elevated plus maze (EPM)
The elevated plus maze test was used to assess if dnSNARE mice exhibited or not an 
anxious phenotype [113]. 
Regarding mice preference for open or closed arms, given by the percentage of time spent 
in each EPM arms, a two-way repeated measures ANOVA test revealed no significant 
differences between groups, whether female and male mice where considered together  (fig. 
4.8 A) in the analysis or not (fig. 4.8 B). In the second analysis, although there were no 
significant different between groups, dnSNARE male mice tend to spent less time in closed 
arms (wt ♀: 52.9 ± 3.1; wt ♂: 55.6 ± 4.1; dnSNARE ♀: 51.4 ± 6.4; dnSNARE ♂: 47.8 ± 1.8) 
that apparently is compensated by the time spent in area that links the two opposite arms of 
Figure 4.7. Mice genotyping. A- Agarose gel (1% in TAE buffer) with the PCR products of the 4 
possible band patterns in for the mice genotyping results. L: ladder (#SM1331, Fermentas); a: wt 
(C57/Bl6); b: double positive, dnSNARE; c: tetO.dnSNARE ; d: wt (C57/Bl6); d; B- Frequency 
distribution of the genotypes from the animals generated in the mattings between mice lines 
GFAP.tTA and tetO.dnSNARE used for the behaviour testing.
BA
1000 b.p. 
700 b.p. 
200 b.p. 
dL a b c
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the plus maze - hub (wt ♀: 13.7 ± 1.9; wt ♂: 13.8 ± 1.10; dnSNARE ♀: 13.2 ± 2.4; dnSNARE 
♂: 20.7 ± 2.1). 
Figure 4.8. Time spent (as percentage of total, %) in the arms and hub of the EPM.  A - wt and 
dnSNARE mice, females and males plotted together; and B - wt and dnSNARE mice, females and 
males plotted separately. Data plotted as mean ± SEM. 
B
A
The number of entrances in open or closed arms did not significantly differ between the 
groups, either considering both gender together (open arms, wt: 9.0 ± 0.9; dnSNARE: 9.9 ± 
1.2; closed arms, wt: 10.1 ± 1.0; dnSNARE: 11.1 ± 1.4 -  fig. 4.9 A) or separately (open arms, wt 
♀: 8.6 ± 1.1; wt ♂: 9.5 ± 1.4; dnSNARE ♀: 10.6 ± 1.7; dnSNARE ♂: 8.7 ± 1.5; closed arms, wt 
♀: 9.5 ± 1.5; wt ♂: 10.9 ± 1.3; dnSNARE ♀: 10.2 ± 1.9; dnSNARE ♂: 12.7 ± 1.9 - fig. 4.9 B). 
The same result was observed in what concerns to the number of arm explorations of female 
and male together (open arms, wt: 14.5 ± 1.0; dnSNARE: 17.1 ± 1.9; closed arms, wt: 13.3 ± 
1.1; dnSNARE: 15.4 ± 2.3 -  fig. 4.10 A) and separately (open arms, wt ♀: 14.5 ± 1.6; wt ♂: 
14.5 ± 1.4; dnSNARE ♀: 14.8 ± 2.4; dnSNARE ♂: 21.0 ± 1.5; closed arms, wt ♀: 12.9 ± 1.4; wt 
♂: 13.8 ± 1.8; dnSNARE ♀: 13.0 ± 2.5; dnSNARE ♂: 19.3 ± 4.1 - fig. 4.10 B), indicating the 
preservation of the exploratory and locomotor activity within all groups of animals. 
Nevertheless, male dnSNARE mice tended to explore more both open and closed arms.
38
Figure 4.9. Number of entrances in open arms and closed arms of the EPM. A - wt and dnSNARE 
mice, females and males plotted together; and B - wt and dnSNARE mice, females and males plotted 
separately. Data plotted as mean ± SEM.
B
A
Figure 4.10. Number of explorations in open arms and closed arms of the EPM. A - wt and 
dnSNARE mice, females and males plotted together; and B - wt and dnSNARE mice, females and 
males plotted separately (B). Data plotted as mean ± SEM. 
B
A
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4.2.2.B. Open Field test (OF)
The spontaneous locomotor activity, exploratory behaviour and also possible anxiogenic-
like behaviour (tendency to spend more time in the periphery, close to the walls - 
thigmotaxis) of dnSNARE mice were further analysed in a OF arena [116]. 
In what concerns to the locomotor activity, no significant differences were found in the 
distance travelled (fig. 4.11 A and B) and velocity between wt or dnSNARE mice (fig. 4.12 A 
and B), considering both genders together or separately. In the first parameter, t-test sowed 
no significant differences between the groups (wt: 2906.0 ± 194.0 cm, dnSNARE: 2907.0 ± 291 
cm; t=0.0, p>0.05) and a two-way ANOVA revealed no differences in the distance travelled 
within mice of the same genotype but different sex (wt ♀: 2824.3 ± 315.8 cm, wt ♂: 2977.7 ± 
254.4 cm, dnSNARE ♀: 2833.4 ± 274.3 cm, dnSNARE ♂: 3005.9 ± 658.9 cm). In the velocity, 
no differences were evidenced by the t-test considering the two genotypes (wt: 9.1 ±  0.78 
cm/s, dnSNARE: 8.9 ± 0.7 cm/s, t=0.6, p>0.05), and by the two-way ANOVA, taking to 
account both genotype and sex (wt ♀: 9.6 ± 1.3 cm/s; wt ♂: 8.5 ± 0.9 cm/s ; dnSNARE ♀: 
7.6 ± 1.0 cm/s; dnSNARE ♂: 9.3 ± 0.6 cm).
The exploratory behaviour, given by the number of rearings that mice do during the 5 
minutes of testing in the OF, was similar between both genotypes - fig. 4.13 A (wt: 50.1 ± 5.2 
and dnSNARE: 60.3 ±3.3, t=1.3, p>0.05) and gender within each genotype - fig 4.13 B (wt ♀: 
43.3 ± 4.2,  wt ♂: 56.1 ± 8.7, t=1.3, p>0.05; dnSNARE ♀: 59.7 ± 5.8, dnSNARE ♂: 61.0 ± 3.1, 
t=0.1, p>0.05 ).
Figure 4.11. Distance travelled (cm) in the open field arena. A -  wt and dnSNARE mice, females 
and males plotted together;  and B -  wt and dnSNARE mice, females and males plotted separately. 
Data plotted as mean ± SEM. 
A B
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The last parameter analysed in the OF test, time spent on centre, was also similar in 
dnSNARE mice and their wt littermate controls. Comparing the two genotypes including 
females and males, t-test showed no significant differences (wt: 21.6 ± 4.1, dnSNARE: 17.7 ± 
2.2, t=0.63, p>0.05 - fig. 4.14 A) as well as no significant effect of gender was evidenced in 
either wt or dnSNARE mice, by the two-way ANOVA (wt ♀:18.0 ± 4.5,  wt ♂: 24.8 ± 6.7; 
t=0.1, p>0.05; dnSNARE ♀: 17.0 ± 3.8, dnSNARE ♂: 18.6 ± 1.9, t=0.7, p>0.05 - fig. 4.14 B). 
This means that wt and dnSNARE mice, either female or male, have similar thigmotaxic 
behaviour when subjected to the OF test.
A B
Figure 4.13. Number of rearings in the open field arena. A -  wt and dnSNARE mice, females and 
males plotted together;  and B - wt and dnSNARE mice, females and males plotted separately. Data 
plotted as mean ± SEM.
A B
Figure 4.12.  Velocity (cm/s) in the open field arena.  A - wt and dnSNARE mice, females and 
males plotted together; B - wt and dnSNARE mice, females and males plotted separately. Data 
plotted as mean ± SEM. 
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Figure 4.14.  Time (as percentage of total,  %) spent in the center of the open field arena. A - wt and 
dnSNARE mice,  females and males plotted together; and B - wt and dnSNARE mice, females and 
males plotted separately. Data plotted as mean ± SEM.
A B
4.2.2.C. Water maze based tests
Following the characterisation of the locomotor activity, exploratory and anxiogenic 
behaviour, mice performed cognitive tests to assess their learning and memory abilities, and 
check whether astrocytic vesicular release is important for these tasks. The first cognitive 
tests performed were the water maze based tests, that aim to evaluate the spatial reference 
memory and the reversal learning of dnSNARE animals in comparison to their littermate wt 
controls.
The spatial reference memory task of the water maze revealed spatial memory 
impairment of the dnSNARE mice, since in the last day of the task they needed significantly 
more time to find the submerged platform than wt animals, when analysing female and male 
animals together (day 4, wt: 29.4 ± 4.9 s, dnSNARE 66.5 ± 12.1, t=3.4, p<0.01 - fig 4.15 A). 
However, this impairment is no longer evident if female and male animals where considered 
separately within the two genotypes (day 4, wt ♀: 32.3 ± 7.9 s, wt ♂: 25.9 ± 5.5 s,  dnSNARE 
♀: 62.4 ± 15.4 s, dnSNARE ♂: 73.5 ± 23.1 s - fig. 4.15 B).
In the reversal learning task mice were required to find the platform in the quadrant of 
opposite location (Q2) relative to the one in the spatial reference memory task (Q4). The 
ability of learning a new location of the platform was assessed in terms of the mean 
percentage of time spent in each of the imaginary quadrants along the 3 trials of the task. The 
more time spent in the Q2, the more capable mice were to find the platform in its new 
location. Through the MANOVA test and Bonferroni post-hoc tests significant differences 
were found, within groups, in the time spent in each of the imaginary quadrants, by wt mice 
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(Q1: 25.8 ± 1.4 %, Q2: 32.2 ± 1.9%, t=2.4, p<0.05; Q2: 32.2 ± 1.9 %, Q3: 21.7 ±  1.5 %,  t= 3.9, 
p<0.001; Q2: 32.2 ± 1.9 %, Q4: 20.2 ±  1.9 %,  t= 4.5, p<0.001) and dnSNARE mice (Q2: 32.4 ± 
3.1 %, Q4: 19.2 ± 1.6 %, t= 3.3, p<0.01) - fig. 4.16 A. However, no significant differences were 
found in the time spent in each quadrants between groups of mice. Furthermore, taking into 
account both genotype and gender of animals in each group (fig. 4.16 B), significant 
differences were found within animals of the same group and sex regarding the time spent in 
the quadrant of the new location of the platform (Q2), when compared to the time spent in 
other quadrants (wt ♀: Q2,  30.4 ± 2.5 %,  Q4, 21.0 ± 2.6 %, t= 2.7, p<0.05; wt ♂: Q2, 34.4 ± 2.7 
%, Q3, 19.7 ± 1.3 %, t=3.8, p<0.01; Q2,  34.4 ± 2.7 %, Q4,  19.2 ± 2.8 %, t= 3.9, p<0.001; 
dnSNARE ♀: Q2, 33.9 ± 4.9 % and Q4, 19.9 ± 2.2 %, t= 2.8, p<0.05). Overall, it is notorious 
that mice with astrocytic dysfunction and their littermate controls were able to learn the new 
location of the platform, indicating an intact reversal learning.
Figure 4.15.  Escape latency (s) in the spatial reference memory task, RMT. A - Escape latency by 
genotype, with both gender plotted together; and B - Escape latency by genotype, with both gender 
plotted  separately, in mice with astrocytic dysfunction (dnSNARE) and their littermate controls (wt). 
Data plotted as mean ± SEM. ** p<0.01, compared to wt littermate controls.
A B
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Figure 4.16.  Performance in the reversal learning task, RLT. A - time (%) spent in each of the 
imaginary quadrants of the water maze by mice with astrocytic dysfunction (dnSNARE) and their 
littermate controls (wt),  plotted per genotype; and B - time (%) spent in each of the imaginary 
quadrants of the water maze by mice with astrocytic dysfunction (dnSNARE) and their littermate 
controls (wt), plotted per genotype and sex. Dotted line represents performance at chance level (25%). 
Data plotted as mean ± SEM; * p<0.05, **p<0.01, ***p<0.001. 
A B
4.2.2.D. Continuous spontaneous alternation test
While the water maze based tests assessed spatial reference memory and reversal learning 
of wt and dnSNARE animals, the continuous spontaneous alternation test allowed to 
characterise the spatial working memory of these animals. Making an overall analysis, with 
no gender discrimination, to the percentage of arm alternations (alternation score, %) from 
the two mice groups, t-test showed no significant differences between wt and dnSNARE 
mice (wt:  28.0 ± 1.6 %; dnSNARE: 29.2 ± 2.4 %, t=0.4, p>0.05) - fig 4.17 A. However, when the 
animals gender was taken into account for the statistical analysis, significant differences were 
found between subjects of different genotype and within the same gender - dnSNARE male 
mice have higher alternation score which means improved working memory, when 
compared to their littermate wt male controls (wt ♂: 26.2 ± 1.6 %, dnSNARE ♂: 36.7 ± 3.3 %, 
t=2.5, p<0.05). Regarding female subjects, no differences were found between both genotypes 
(wt ♀:  29.0 ± 2.6 %, dnSNARE ♀: 27.5 ± 1.1 %, t=0.6, p>0.05) - fig 4.17 B. As no genotype-
effect (wt: 24.3 ± 1.0 %, dnSNARE: 21.5 ± 0.6 %, t= 1.8, p>0.05 - fig. 4.18 A) or genotype-by-
sex interaction (wt ♀: 23.2 ± 1.3 %, dnSNARE ♀: 21.6 ± 0.6 %, t=0.8, p>0.05; wt ♂:  25.8 ± 1.7 
%, dnSNARE ♂: 21.3 ± 0.9 %, t=1.7, p>0.05 - fig. 4.18 B) were observed regarding the total 
number of arm entries, the greater alternation score of dnSNARE male mice is attributable to 
an improved spatial working memory and not to a greater locomotor activity or motivation 
to explore the maze.
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Figure 4.18.  Total arm entries in the continuous spontaneous alternation task, performed in the Y-
maze. A - total arm entries of mice with astrocytic dysfunction (dnSNARE) and their littermate 
controls (wt), plotted per genotype; and B -  total arm entries of mice with astrocytic dysfunction 
(dnSNARE) and their littermate controls (wt), plotted per genotype and sex. Data plotted as mean ± 
SEM. ; n. s. p>0.05.
 
A B
Figure 4.17.   Arm alternation (alternation score, %) in the continuous spontaneous alternation task, 
performed in the Y-maze. A - alternation score of mice with astrocytic dysfunction (dnSNARE) and 
their littermate controls (wt),  plotted per genotype; and B -  alternation score of mice with astrocytic 
dysfunction (dnSNARE) and their littermate controls (wt), plotted per genotype and sex.  Data plotted 
as mean ± SEM. ; n. s. p>0.05,  * p<0.05.
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5.  DISCUSSION AND CONCLUSION
The main aim of this work was to implement and study animal models of astrocytic 
dysfunction and assess if these animals would display cognitive differences when compared 
to the respective controls, as a way to dissect the astrocytic role in the construction of 
complex behaviour outputs. Here we show the implementation process and the first results 
of the behavioural phenotype characterisation of learning and memory, in the two models: 
one pharmacological rat model, with a single bilateral intracranial injection of L-α-
aminoadipate in the mPFC that depletes astrocytes in the region; and one genetic mice 
model, consisting of a conditional blockade of the exocytotic release in astrocytes by means 
of a “tet-Off” system. 
 During the establishment of the first model, multiple parameters required careful 
adjustment: from the surgical procedure for the cannula implementation (the choice of 
stereotaxic coordinates and the method of fixing the cannula to the skull); recovery period 
before drug administration; drug administration (concentration, vehicle and infusion rate, 
and methods for rat restraint during the drug infusion - implicating the establishment of a 
new anaesthesia protocol); lag phase between drug administration and behavioural testing; 
to histological analysis (brain sections immunofluorescence) and correlation to the 
behavioural output of rats with astrocytic ablation. Nevertheless, after all parameters were 
defined, the experiments carried out with this rat model of pharmacological astrocytic 
ablation provided us several interesting results.
Before the behavioural output analysis, we started to get an insight into the real location 
of the cannula and into the extent of the lesion caused by the drug injected through the 
bilateral internal cannula, as well as the kind of collateral damage due to the cannula 
implantation itself. By following the established stereotaxic coordinates, we were able to 
target the medial and dorsal portions of the PrL and the Cg regions of the PFC. The 
determination of the number of GFAP- and NeuN-positive cells, through confocal imaging, 
allowed to further characterise the cortical tissue subjected to the injections of L-α-AA or 
aCSF. The observation of astrocyte depleted areas within the mPFC of animals that 
performed ASST and water maze based tests evidenced the astrocyte ablation by L-α-AA as a 
dynamic lesion. Apart from complete absence of GFAP staining in the lesion site of animals 
injected with L-α-AA, we observed that the lesions in animals that performed water maze 
tests (sacrificed 7 days post-drug infusion) were relatively smaller than the ones observed in 
animals that performed ASST (sacrificed 3 days post-drug administration), although due to 
the method of selection of brain sections we could not quantify the lesion size. This 
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observation correlates with the dynamic status of the L-α-AA caused astrocyte ablation [89]. 
Moreover, this fact suggests a repopulation of the lesioned area by other astrocytes whose 
origin and functional integration into the existing glial network needs to be clarified [120]. 
Despite of the absence of astrocytes within lesioned areas, the number of neurons was not 
affected within these areas.
From the behaviour assessment of the rats subjected to the bilateral intracranial injections 
of L-α-AA we could conclude that the astrocytic ablation in the mPFC affects the attentional 
set-shifting, the working memory and the reversal learning. First, by performing the ASST, 
AA animals have shown difficulty to discriminate textures in the SDT stage, but this was not 
observed in the precedent discrimination of odours because rodents are very sensitive to 
olfactory stimuli [121]. Apparently, astrocyte depletion impairs the learning of the 
discrimination of stimuli from a new dimension (texture). In CDO and EDST (corresponding 
to a compound discrimination of textures), animals injected with the gliotoxin have shown 
similar performance to the control animals. But the depletion of astrocytes caused a 
strikingly worse performance in the reversal stages, which indicates an impairment of the 
reversal learning. These observations are consistent with the fact that the mPFC mediates 
shifts between new strategies or rules [122]. Nevertheless, these observations do not comply 
with the data observed in the RLT of the water maze, as the similar performance of AA and 
CON animals in the reversal learning and probe task of the water maze based tests (7 days 
post-injection) suggests that were not result of the astrocyte depletion lesions. That could be 
explained by the fact that astrocyte ablation lesions were considerably smaller in animals 
that performed water maze based tests, than in animals that performed ASST [89]. 
Concerning the other tasks of the water maze based tests, astrocyte depleted animals 
displayed impaired working memory, which is a cognitive function dependent on the 
regions affected [99]. The learning curve in the RMT was similar in both groups of animals, 
except for the first day of this task, where differences between groups escape latencies reflect 
a working memory impairment in AA animals. Indeed, an intact mPFC is necessary for 
proper working memory, but not for spatial learning and memory [110].
Together, these observations go against the classical concept that learning and memory 
processes are exclusively result of the neuronal activity and supports the tripartite synapse 
theory [32], meaning that  astrocytes are crucial for such cognitive processes.
In order to identify a possible mechanism for the effects observed in the astrocyte 
depletion model, we implemented the dnSNARE mice model [106] at our lab, so that we 
could study the impact of astrocytic vesicular release of neurotransmitters in the build-up of 
complex behaviour forms. For the establishment of the transgenic mice dnSNARE model in 
our lab, the GFAP.tTA and tetO.dnSNARE mice lines kindly supplied by the lab of Philip 
Haydon (Tufts University, Boston) were first maintained in heterozygous state before we 
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could start with the mattings between mice of these two lines. Animals GFAP.tTA and 
tetO.dnSNARE generated by the back-crossings were then mated to produce dnSNARE 
mice. This whole process lasted for several months, since we needed a considerable number 
of animals suitable to perform all behaviour testis (at least 3 animals of each genotype and 
sex). Once mice from the mattings between the two different mice lines reached 10 weeks old 
they, we had for the first time in our lab mice with exocytotic release blockade in astrocytes 
ready to behaviour phenotype characterisation. Initially, our main focus was to characterise 
dnSNARE behavioural performance in cognitive tests that assessed learning and memory, 
but as this mice line was being established for the first time in our lab, we decided to go 
further on the behavioural phenotype characterisation. Hence, we opted to test these animals 
in the EPM, the OF, the water maze tests and the continuous spontaneous alternation test in 
the Y-maze to screen additionally for cognition, exploratory motivation, locomotion 
difficulties or anxiety, as this mice strain was only tested by other groups by the the novel 
object recognition task [40, 90], in the context of sleep deprivation, and in the zero maze, to 
assess anxiety levels [40].
In the EPM test, mice preference for closed arms was not different from their preference 
for closed arms, regarding genotype and sex, meaning that wt and dnSNARE animals have 
the similar anxiety level. However, male dnSNARE mice tended to spend less time in the 
closed arms, apparently compensated by the time spent in the hub. But since the number of 
arm entries and explorations was similar in all mice groups, the tend for dnSNARE male 
mice spend less time in closed arms and to explore more both open and closed arms was not 
due to different locomotor and exploratory activity. These similarities in the anxiety level of 
dnSNARE mice and littermate wt controls assessed in the EPM are consistent with the ones 
already reported in the zero maze by Halassa and colleagues [39]. This means that the fact 
that the blockade of exocytotic release in astrocytes per se is not sufficient to cause an 
alteration in the anxiety patterns in these animals.
Open field arena testing revealed no significant differences between wt and dnSNARE 
mice locomotor activity (distance travelled and velocity), exploratory behaviour (rearings) 
and thigmotaxis (related to the time spent in the centre of the arena). The thigmotaxis results 
of wt and dnSNARE mice are coherent with the similar anxiogenic level between these 
animal observed by us in the EPM. Once again, we can say that the condition of astrocytic 
dysfunction in terms of vesicular release has no impact in the locomotor activity, exploratory 
and thigmotaxic behaviour.
Since we achieved the characterisation of locomotor, exploratory and anxious behaviour 
in mice with astrocytic dysfunction and confirmed that both genotypes were similar in these 
characteristics (and therefore they would not influence the motivation to perform additional 
tests) we aimed to further characterise these dnSNARE and wt littermates in what concerns 
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to their learning and memory abilities. The water maze based tests revealed an impairment 
of the spatial reference memory of dnSNARE animals when compared to littermate wt 
controls, with no gender discrimination. However these differences are no longer evident 
when female and male mice from the two genotypes were considered to the analysis 
separately. This means that the gender of the animals has no effect in the behavioural output 
of control and dnSNARE mice and suggests that differences are only evident when the 
number of animals per group is increased. Following the reference memory task, wt and 
dnSNARE animals performed the RLT, on which animals from both genotypes have learnt 
the new location of the platform (Q2). Even so, wt animals seem to be more effective than 
dnSNARE animals in the learning of the new platform location, as the first spent 
significantly more time in the Q2 than in any other quadrant, while the time spent by the 
seconds in the Q2 was only significantly different in comparison to the Q4. Apparently, wt 
animals are more objective when navigating towards the platform, while the navigation of 
dnSNARE animals seems more disperse in the four quadrants of the water maze. The 
analysis of this data separately for females and males from each group evidenced that both 
female and male wt mice were able to learn the new location of the platform, while within 
the dnSNARE genotype, only female could learn to reach the platform in the Q2, instead of 
the Q4. 
With the water maze tests we could, assess the reference memory, dependent on the 
hippocampus and the reversal learning, dependent on the PFC. Since we were interested in 
further characterise the PFC function of dnSNARE, we opted to also test them through the 
continuous spontaneous alternation test in a Y-shaped maze. This test allowed us to 
characterise the terms of spatial working memory of animals with astrocytic dysfunction. 
When placed in the centre and allowed to explore the maze during 5 minutes, dnSNARE 
male animals revealed improved working memory, as they got a higher alternation score 
than wt male mice, even with similar locomotor and exploratory activity, comparing to other 
groups of animals, of different genotype and sex.
To our knowledge, we are first reporting behavioural phenotype characterisation of 
dnSNARE mice terms of: anxiety level in the elevated plus maze; locomotor, exploratory and 
thigmotaxic activity in an OF, spatial reference memory and reversal learning in a water 
maze and spatial working in a Y-shaped maze. Along all this behavioural phenotype 
characterisation, we could observe that the gender may have an effect in the behaviour 
output of the dnSNARE animals. This idea is supported by the results obtained in the 
reversal learning task of the water maze bases tests and also in the continuous spontaneous 
alternation test. In either of those, male dnSNARE animals revealed a behaviour phenotype 
distinct from female subjects: in the reversal learning task of the water maze based tests, 
female subjects had better performance, while in the continuous spontaneous alternation 
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task male subjects have performed better. Therefore, the performance of males and females 
should be considered individually, at least in water maze tests and in the continuous 
spontaneous alternation test.
Overall, astrocyte depletion in the mPFC induced and impairment of behavioural 
functions dependent on this region, such as working memory and reversal learning. These 
findings are in line with the data obtained from the cognitive characterisation of the 
dnSNARE mice, which display impaired vesicular release by astrocytes and therefore 
impaired gliotransmission. Altering astrocytic function at this level causes changes in the 
behaviour output, as these animals showed impairment in the reference learning and 
curiously an improvement in working memory. It seems that the outputs observed require 
different mechanisms, which represent new scientific questions in this field. In the case of 
the gliotoxin astrocytic depletion, it is obvious that all the astrocyte functions in brain 
metabolism (bridging the nutrient passage from blood to neurons) [24] and homeostasis of 
ions ([K+] and [H+]) [16] and neurotransmitters [14, 17-20] are arrested in lesioned sites, 
compromising the neuronal activity in those region. Besides the classically accepted 
functions of astrocytes [15], all the astrocytic implications in the modulation of the synaptic 
transmission [32] and integration of neuron-glia circuits [41] are also interrupted. Therefore, 
it would be expectable that the cognitive functions of the gliotoxin-injected animals would be 
somehow compromised. However, as the lesion caused by L-α-AA is so severe, the 
dissection of the mechanisms underlying the obtained behavioural phenotypes gets 
complicated. With the assessment of the behavioural phenotype of the dnSNARE mice, the 
behavioural output of these animals is easily attributed to the blockade of the gliotransmitter 
release in GFAP-expressing astrocytes, since the formation of SNARE complex for the 
docking of gliotransmitter-containing vesicles does not occur in these animals [106, 107]. 
Nevertheless, we cannot point out which of the absent gliotransmitters is making the 
difference, but we can speculate about it. Could be ATP or glutamate, once these are the most 
recognised chemical transmitters that mediate astrocyte-neuron signaling [123], or even D-
serine, because it has been recently identified as major gliotransmitter in the central nervous 
system that serves as an endogenous ligand for the glycine site of NMDA receptors [55, 
124-127]. However, either glutamate or D-serine seem to have more relevance because the 
most common forms of synaptic plasticity found in the brain are dependent of the activation 
of NMDA receptors, including long-term potentiation (LTP) and long-term depression (LTD), 
which are in the cellular substrates of cognitive learning and memory [128].
We show here interesting results, regarding the influence of astrocytes in complex 
cognitive functions. However, further studies are required to help the elucidation of the 
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mechanisms involved such as using electrophysiological and neurochemical techniques to 
understand how brain dynamics are altered and if those alterations can be correlated with 
others observed under pathological states.
With the present work we have attained the successful implementation in our lab of two 
different animal models of astrocytic pathologies. The aminoadipate pharmacological rat 
model, was established through surgery and post-recovery drug infusion, while the 
transgenic mice model required multiple mattings between different mice lines and selection 
of offspring for the obtention of the dnSNARE animals and their wt littermate controls. 
Despite the distinct nature of these two animals models, we were able to characterise its 
behaviour phenotype in the pathological conditions induced, leaving these available for 
further studies in our lab. From now on, we can use these models to study brain function in 
conditions of stress or dementia to try to disclose more about astrocytes role.
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